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ABSTRACT
The realization of high throughput sample processing has become a primary
ambition in many research applications with an example being high throughput
screening (HTS), which represents the first step in the drug discovery pipeline.
Microfluidics is a viable platform for parallel processing of biochemical reactions to
increase data production rates due to its ability to generate fluidic networks with a high
number of processors over small footprints suitable for optical imaging. Single-molecule
detection (SMD) is another technology which has emerged to facilitate the realization of
high throughput data processing afforded by its ability to eliminate sample processing
steps and generate results with high statistical accuracy. A combination of microfluidics
and SMD with wide-field fluorescence detection provides the ability to monitor
biochemical reactions in a high throughput format with single-molecule sensitivity. In this
dissertation, the integration of these techniques was presented for HTS applications in
drug discovery.
An ultra-sensitive fluorescence detection system with a wide field-of-view (FoV)
was constructed to transduce fluorescence signatures from single chromophores that
were electrokinetically transported through a series of tightly packed fluidic channels
poised on poly(methylmethacrylate), PMMA and contained within the FoV of a laser
detection system. The system was used to monitor biochemical reactions at the singlemolecule level in a continuous-flow format. Enhancement in sampling-throughput was
demonstrated by constructing a high density fluidic network for parallel analysis of
multiple biochemical assays. In another development, the ability to enhance singlemolecule sensitivity in a flow-based biochemical assay was investigated using a novel
cyclic olefin copolymer (COC) planar waveguide embedded in PMMA and situated
xxii

orthogonal to multiple fluidic channels. This design allowed for fluorescence detection
from multiple fluidic channels using evanescent excitation and a wide FoV fluorescence
detection system for parallel readout. Results from these technologies were presented
as well as their applications in drug discovery for increasing data production rates and
quality.
An approach toward monitoring the efficacy of therapeutic agents, which is
important in clinical evaluation of drug potency in the drug discovery process, was also
considered, by designing a microfluidic system with integrated conductivity sensor for
label-free enumeration of isolated tumor cells from clinical samples.
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INTRODUCTION
I.1 Overview of the Drug Discovery Process
Drug discovery research is an interdisciplinary endeavor, which has been
increasingly propelled by chemistry and guided by pharmacology and the clinical
sciences with deep impact from molecular biology and the genome sciences. The latter,
combined with bioinformatics’ tools, allows us to clearly understand the genetic basis of
diseases and to determine the most suitable sites of attack for future therapeutic
agents. Thus, novel chemical structures with drug-like properties are generated through
a discourse between biologists and chemists, with adequate understanding of biological
structures and functions that define the biological mechanism of action.1,2 The advent of
combinatorial chemistry has led to the generation of diverse sets of novel organic
compounds (structure-based synthesis) to form large libraries of small molecules
(combinatorial libraries),3-6 with each generated molecule being subjected to a series of
purification and characterization processes followed by screening the entire library
against a particular target to register potential drug candidates that can enter clinical
trials.7 An overview of the drug discovery process is represented in Figure I.1. It takes
10–15 years or more with an enormous financial investment (in excess of $500 million)
to bring a new drug to the market.8 With advancements in scientific research, a number
of new technologies that focus on improving the chances of discovering a new drug,
which could also reduce the time line (discovery cycle) to 5–7 years, have been
introduced. One key technology is centered on improving the efficiency of drug
screening processes using high throughput assays and hardware.
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Figure I.1 Overview of the drug discovery pipeline showing the central role of high
throughput screening (HTS) in the mechanism-based drug discovery process. Adapted
with permission from Aherne et al.8
I.2 High Throughput Screening and High Throughput Sample Processing
The configuration of the screening platform in the drug discovery pipeline for high
throughput processing is vital in maximizing the overall efficiency of the drug
discovery process. This would allow for the ability to process multiple samples in a
parallel fashion with a resultant reduction in the time requirement for the drug
screening process. High throughput sample processing has also become the
primary goal in other applications, such as molecular diagnostics and genome
sequencing due to the large number of samples that must be interrogated. Obviously
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from the illustration shown in Figure I.1, high throughput screening (HTS) plays a
pivotal role in the drug discovery process with its utility spreading from the structurebased design or analogue synthesis of compounds (combinatorial chemistry) via the
‘hit to lead’ process to the generation of preclinical drug candidates.8 Thus, HTS has
remained the essential starting point in the drug discovery process and has rapidly
evolved into a highly efficient, robust, integrated and information-rich scientific
discipline. Assay throughput has been continuously increased from the traditional
96-well plates to higher density plate systems, for example, the use of microtiter
plates with a 9,600-well configuration.9-12 The increasing demands to screen larger
libraries of compounds against a number of therapeutic targets has incited
technological advancements towards automated HTS. This trend was accompanied
by miniaturization to reduce development and operating costs as well. While
miniaturization facilitates assay automation and the realization of higher throughput
formats through the use of parallel sample processing, it also reduces the amount of
precious biological materials and chemical reagents used per assay.
This advancement and need is being pursued through the use of microfabricated
devices designed to perform continuous flow assays appropriate for HTS.13,14 For
example, the potential of microfluidic systems for large-scale and high performance
screening was demonstrated through the use of microfabricated microchannel array
systems with automatic sample loading from microtiter plates to screen 96 samples
in less than 90 s.15 The ultra-small sample volume associated with miniaturization
was accompanied with detection challenges due to the ultra-small sampling volume
and thus, required the use of sophisticated and high sensitivity detection techniques
to readout the assay results.
3

I.3 Assay Readout Methods
The development of homogeneous assays and the use of high sensitivity
detection techniques have become increasingly important in the pursuit of
automation, miniaturization, and high throughput in the drug screening process. It is
highly required that miniaturized assays be properly designed with suitable readout
methods to ensure robustness and reproducibility as well as statistical significance
of the assay results.16
Homogeneous screening assays are most frequently carried out using
scintillation proximity assays (SPA) or fluorescence detection techniques depending
on the particular type of target being investigated.17 Whilst most binding assays for
cell surface receptors are often performed using SPA techniques, fluorescent-based
methodologies that employ samples such as fluorogenic enzyme substrates, dyelabeled substrates and fluorescent indicators for calcium and other ions are
frequently used in enzyme and cell-based assays.17,18 Other methodologies based
on phage-display techniques or heterogeneous assay formats, for example ELISA
and agar plate assays19 have also been employed for screening. Given below will be
a brief description of the SPA and fluorescence-based assays typically used in HTS.
I.3.1

Scintillation Proximity Assay (SPA)
The use of SPA techniques20,21 to measure high affinity binding
interactions for cell surface receptors in HTS applications has largely replaced
radio-labeled ligands and filtration assays due to the ability of SPA to eliminate
separation steps. The technique is essentially based on measuring light emission
from a surface bound scintillant as a function of binding interactions between a
radio labeled ligand and surface immobilized receptor. Isotopes that produce low
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energy emission particles are typically used to ensure that only surface bound
ligands are detected.22-25
I.3.2

Fluorescence-Based Techniques
Fluorescence-based methodologies are becoming increasingly more
popular for HTS applications due to the inherent sensitivity of fluorescence
measurements and the industry-wide drift from the use of radioisotopes.
Fluorescence techniques most widely used in homogeneous screening assays
includes

fluorescence

resonance

energy

transfer

(FRET),

fluorescence

polarization (FP), homogeneous time-resolved fluorescence (HTRF), and
fluorescence correlation spectroscopy (FCS).26,27
•

Fluorescence Resonance Energy Transfer (FRET):

This is

essentially a non-radiative energy transfer between donor and
acceptor dye molecules with transfer efficiency being dependent on
spatial criteria.28 It can be used to monitor enzymatic activities by
measuring changes in observed fluorescence intensity resulting from
substrate cleavage by the enzyme such that donor and acceptor drift
apart.29-31
•

Fluorescence Polarization (FP): Changes in the rotational diffusion
coefficient of small labeled probes upon binding to target molecules is
measured using FP techniques.32 This technique provides rapid
analysis of receptor-ligand binding interactions, enzyme-catalyzed
hydrolysis of labeled substrates, protein-protein interactions and other
binding assays of interest to HTS.33,34
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•

Homogeneous Time-Resolve Fluorescence (HTRF): Fluorescence
signals

from

homogeneous

samples

are

often

hampered

by

background signal arising from sample matrix. One method of
minimizing this problem is through the use of the time-resolved
technique in which pulsed excitation sources and gated detectors are
employed to allow the decay of background fluorescence before
sampling the fluorescence signal of interest. HTRF utilize the
advantage offered by europium crystates (i.e. long fluorescence life
time and large stokes shift) to exploit energy transfer between an
europium donor and suitable acceptors for screening applications.35,36
•

Fluorescence Correlation Spectroscopy (FCS): FCS has emerged
as a suitable detection technique for HTS applications.37 In this
technique, measurements are carried out using confocal optics to
provide focused excitation light with the associated reduction in probe
volume such that temporal fluctuations in signal as molecules diffuse in
and out of the probe volume is observed. Autocorrelation analysis of
time-dependent fluorescent signals generate information about the
diffusion characteristics of the particles or molecules. This technique is
also used for monitoring binding interactions since the binding of a
fluorescence probe to another molecule results in a change in its
diffusion coefficient. It is used in registering molecular events and has
demonstrated potential for HTS applications.37,38

Chemiluminescence39

and

electrochemiluminescence40

have

both

shown

detection sensitivities that compete with those of fluorescence and are suitable
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for HTS applications.41 Electrochemiluminescence takes preeminence for HTS
applications since reagents can be regenerated to sustain high photon flux rates
over longer periods of time.
I.4 Need for Single-Molecule Sensitivity
Single molecule detection (SMD) represents the highest sensitivity in any
analytical measurement and therefore possesses the ability to eliminate sample
processing steps in multi-step assays as well as providing exquisite analytical
sensitivity. For example, SMD provides the ability to detect biological
components in their native concentrations without sample enrichment steps such
as PCR amplification, and can record subtle changes in biochemical reaction
profiles. In addition, SMD reveals detailed information on molecular behavior
such as complex fluctuations phenomena that are otherwise hidden within
ensemble average techniques.42-45 These, together with the reduced assay time
and short readout times associated with SMD, have given the technique
immense recognition as a powerful analytical tool for biochemical assays
especially in enhancing high throughput sample processing.26,46,47 The major
advantages of SMD toward HTS are high statistical accuracy, even at
measurement times of ~1 s, the ability to provide for the sensitivity demand of
HTS with the pursuit of miniaturization,48-52 and most importantly, the low
consumption of precious biological materials brought about by the ability to
monitor reactions efficiently in ultra-small volumes, which provides a drastic
reduction in assay cost.26,46 Typically, the technique employs ultra-small sample
volumes with appropriate sample concentrations that allows sampling of exactly
one molecule at any given time. This is illustrated in Figure I.2
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Figure I.2 Illustration of fluorescence SMD with a tightly focused laser that generates
femtoliter probe volumes such that the appropriate sample concentration is selected to
keep single molecule occupancy at ~0.1. Only one molecule is sampled in the probe
volume at any given time.
I.5 Research Focus
The overarching goal of my research area is the design of a microfluidic system
for drug discovery (HTS) using near-IR fluorescence detection with single molecule
sensitivity. A conceptual rendition of the target fluidic system with high throughput
and automation capabilities is represented in Figure I.3.
In this dissertation, I will focus on the development of ultra-sensitive detection
systems for the rapid flow-based analysis of biological samples in a high throughput
format. In one development, an ultrasensitive fluorescence detection system with a
wide field-of-view (FoV) microscope was constructed to transduce fluorescence
signals from single chromophores that were electrokinetically transported through a
8

Figure I.3 Integrated fluidic system for performing HTS assays. The system will be
configured on a 6” wafer and the wafer shown has 192 processors. The wafer consists
of a stack of fluidic chips, with one chip used for containing the substrates and buffer
reagents required for the HTS, a 96-element transfer chip to move drug candidates to
the processor wafer and the HTS processor chip containing passive mixers, 2-phase
flow generator and detector elements. The system will be operated in a 2-phase flow
format with an inert separator liquid to significantly increase processing throughput.
series of tightly packed fluidic channels poised on PMMA and contained within the
FoV of the detection system. The system was used to monitor biochemical reactions
at the single-molecule level in a continuous flow format. The potential of this system
was expanded through the fabrication of a high density fluidic device (microchip)
with individual reactors (vias) on the polymeric platform with suitability for HTS
applications (drug discovery). In another development, the ability to enhance
sensitivity in a flow-based biochemical assay was investigated using a novel
9

integrated embedded waveguide system. The embedded waveguide was used to
effectively generate evanescence excitation across a series of fluidic channels to
allow parallel excitation with subsequent detection of fluorescence signals from the
fluidic channels. Finally, in another unrelated area, I focused on the development of
a label-free technique using a conductivity sensor for on-chip enumeration of tumor
cells as an approach to early disease diagnosis and monitoring efficacy of
therapeutic agents (clinical evaluation of drug potency), which also form part of the
drug discovery pipeline.
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CHAPTER 1
SINGLE-MOLECULE DETECTION: THE ULTIMATE SENSITIVITY IN ANALYTICAL
MEASUREMENTS
1.1 Introduction
The scientific community has witnessed tremendous progress in the field of
single-molecule research, which is continuously expanding due to technological
advances and the promise of unparalleled capabilities to provide incredible molecular
information that were hitherto hidden in conventional ensemble techniques.

Whilst

standard ensemble methods generate results from large numbers of molecules, which
correspond to their average properties, single-molecule detection (SMD) allows the
interrogation of exactly one molecule in a complex matrix, and represents the ultimate
detection limit defined by the inverse of Avogadro’s number (1.66 x 10

-24

or 1.66

yoctomole). This allows for construction of actual distributions of complex phenomena,
such as folding states of biomolecules, molecular configurations and stages of
enzymatic cycles.1 Another benefit of single molecule studies is the ability to monitor
molecular dynamics. For example, it can give detailed information about the stochastic
motion of DNA enzymes or molecular motors in biological systems. In addition, singlemolecule detection could be a local reporter in the nanoenvironment such that small
changes in its immediate surrounding can be clearly observed. These changes could be
in the form of the presence of reactive functional groups, ions, atoms or electrostatic
charges. Also, the ability to observe individual molecular events eliminates the need for
synchronization, especially for molecules undergoing time-dependent processes such
as triplet state crossing, thus enabling measurement of spectral shift or temporal
fluctuations as a function of natural or induced perturbations in biological systems with
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high efficiency.2,3 Finally, single-molecule methods eliminate sample preprocessing
steps, for example, it allows measurement of native concentrations of cellular
components, which are often present in few copies within biological cells.4-6 The science
of single molecule spectroscopy spans several fields such as physics, chemistry and
biology and thus has promoted excellent collaborations for making key advances in
scientific research.
Early approaches to single-molecule detection included optical detection of
multiply labeled single antibody molecules7 and detection of current from single ion
channels in membranes.8 Subsequently, several exciting developments were made
using various experimental approaches.9,10 These included, optical detection of single
chromophores in solids at low temperature,11,12 detection of single fluorophores under
biologically relevant conditions,13-15 imaging individual DNA molecules in water,16,17 and
measurement of individual kinesin movements along a microtubule.18,19 This field of
research has evolved through the last two decades to a status of a powerful and
compelling technique for exploring molecular behavior at the nanoscale.20,21
A recent search using the PubMed data base (www.pubmed.gov) as conducted
by Ha and coworkers22,23 showed a trend that appeared to be exponential with a
doubling time of 2.2 years (see Figure 1.1) in terms of single-molecule research. This
rapidly increasing research interest in single-molecule studies has motivated frequent
breakthroughs in imaging and analyzing techniques, resulting in over 400 United States
patents24 and consequently facilitating advances in biological sciences. For example,
videos of the motion and biochemistry of macromolecular machines can now be
generated at the single-molecule level, which are helpful in elucidating their mechanism
and could potentially lead to the development of new drugs.24-27
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Figure 1.1 Growth pattern of single molecule fluorescence research (appearing to be
exponential with doubling time of 2.2 years). (a) Number of single-molecule publications
per year. Data was obtained by searching the PUBMED data base with the keyword
“single-molecule fluorescence”. Technical advances in FRET experiments are shown in
gray; (b) technical advances in single-molecule tracking: translocation (purple), rotation
(orange); (c) technical advances in live cells studies (green). Adopted with permision.23
The two primary approaches for SMD are fluorescence and manipulation (force).
Fluorescence techniques for SMD include FRET, polarization, lifetime, localization and
intensity while manipulation includes optical and magnetic tweezers and atomic force
microscopy (AFM). In this review and with regards to our research goal, particular
attention will be given here to fluorescence techniques, however, a detailed discussion
of manipulation methods can be found in selected papers.9,28-33
1.2 Fluorescence Single-Molecule Detection
With emerging technology, the utility of fluorescence spectroscopy in single
molecule studies is becoming even more powerful due to the inherent sensitivity of
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fluorescence detection.23 To be able to probe the molecule of interest, a laser beam is
used to induce electronic transitions with the resulting optical absorption detected
indirectly by monitoring the fluorescence emission.12 Appropriate dilution conditions are
required to ensure that one molecule is resident in the probe volume (analysis volume)
at any given time. This would mean for example, acquiring fluorescent signal from a 1015

liter volume of a 1.66 x 10-9 M (maximum concentration) solution. Obviously,

fluorescence measurements from the molecule of interest is done in the presence of
trillions of solvent molecules as well as noise from the detection system, thus
techniques are employed to spectrally isolate the single-molecule fluorescence from
unwanted signal emanating from its immediate vicinity. This is often achieved through
the use of specially designed interference and/or Raman notch filters.11
1.2.1 Basic Principle of Single-Molecule Fluorescence
There are two basic requirements for realizing single-molecule sensitivity using
fluorescence: (1) the use of ultra small probe volumes and (2) ensuring a signal-to-noise
ratio (SNR) that is greater than unity (SNR >3 gives a statistical result with 99.7%
certainty) for the single-molecule signal. In most fluorescence-based single-molecule
experiments, the small probe volume requirement is obtained by focusing the laser
beam to a diffraction limited spot, however, appropriate concentrations of the analyte
molecule of interest contained in an ultrapure host matrix must also be selected based
on Avogadro’s criterion to keep molecular occupancy lower than unity in the probe
volume. This is important to avoid double occupancy at a reasonable sampling time
such that any signal registered is indeed from a single molecule. The required SNR is
obtained through adequate suppression of background signals, which mainly originate
from undesirable fluorescent impurity in the sample, Raman scattering from the solvent,
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Rayleigh scattered radiation at the pumping wavelength and residual fluorescence from
the optical system.34 The challenge therefore is to increase the signal size from the
single molecule hidden in its host matrix as much as possible. This is achieved, in
addition to using a small focal volume by using fluorophores with large absorption cross
sections, high photostabilities and a weak tendency for triplet state transitions. Also, the
pumping laser must be operated below optical saturation of the molecular absorption.
Although the number of photons emitted by a single molecule per second is much
smaller compared to the number of photons per second from the incident laser beam,
the Stokes’ shift associated with the molecular absorption phenomena makes it possible
to carefully isolate the weak fluorescence from a single molecule. Illustration of the
prominent features in the energy level diagram of single-molecule fluorescence is
shown in Figure 1.2. Typically, the ground state (S0) molecule absorbs energy from the
pumping laser to undergo an electronic transition to a higher electronic energy level
(S1), which quickly relaxes to the lowest energy level of the excited state (S1) from which
fluorescence photons are emitted. Energy losses due to vibrational relaxation causes
red-shifts in the emission wavelength (Stokes shift). The molecule can undergo several
absorption-emission cycles prior to photobleaching. It is also important to note that there
is a finite probability for intersystem crossing (ISC) into the triplet states, which often
results in fluorescence intermittency or photoblinking in single-molecule experiments
depending on the properties of the fluorophore and experimental conditions.35,36
1.2.2 Fluorophore Consideration for SMD
Fluorophores can be referred to as molecular spies in single molecule
experiments with information feedback channels occurring as fluorescence. Thus, when
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attached to biological molecules, they reveal information that depicts the molecular

Figure 1.2 Energy level diagram for single molecule spectroscopy showing the ground
singlet state (S0), first excited state (S1), lowest triplet state (T1), and other intermediate
states. Single molecules can be recycled many times through this scheme to generate
millions of photons. Adopted with permission.20
processes in the vicinity of the host molecule. However, single dye molecules emit
limited amounts of fluorescence, which must be maximized to facilitate a clear
observation of processes when placed in its nanoenvironment. Consequently, an ideal
fluorophore is required for a successful single molecule experiment. Fluorophores
should stay photoactive under intense illumination, possess high absorption crosssections and fluorescence quantum yields, does not modify the properties of the host
molecule and should show steady emission intensity. Typical fluorescent molecules
used for single molecule studies originate from the general classes of laser dyes used in
biological fluorescent labeling. These include rhodamines, cyanines, oxazines, terrylene
or perylene diimide.37-39 In addition, classes of genetically expressed proteins like green
fluorescent protein (GFP) have been employed for single-molecule fluorescence
studies.40,41 In the cyanine family, Cy3 and Cy5 are extensively used either individually
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or as a FRET pair.42-44 These dyes have high photostability and good fluorescence
quantum yields.45 Other popular fluorophore includes Cy5.5 and Cy7. In the rhodamine
family, tetramethylrhodamine,46,47 rhodamine 6G, Texas Red, and bis-sulfonerhodamine
have been used. Other fluorophores of interest includes Alexa dyes23 and some new
classes of single molecule fluorophores found among molecules originally optimized for
non-linear optics.48 In addition, some proteins are naturally fluorescent with the
presence of one or many fluorophores serving as a co-factor, and have been used to
obtain useful information for single-molecule interrogation, for example in the cases of
flavoenzymes49,50 and complexes containing bacteriochlorophyll molecules.51 Novel
fluorescent dyes, such as the phthalocyanine derivatives,52 have been synthesized and
used for molecular single molecule studies as well. These dyes have been
characterized with self quenching, resulting from aggregation and thus eliminate the
need for a separate quencher in RET-based experiments.53
1.2.3 Physical Effects that Limit Fluorescence Emission from Single Molecules
The

major

physical

effect

related

to

single-molecule

fluorescence

is

photobleaching, which is an irreversible process that causes molecules to eventually
change to another, non-fluorescent form. This is true for almost all molecules in
aqueous solution and typically occurs after emission of specific number of photons.
Under favorable conditions, individual molecules can emit on the average 105 – 106
fluorescence photons before photobleaching. Although, there are many factors
responsible for photobleaching, in most cases, it is mainly due to photo-oxidation. Thus,
methods such as flooding the system with inert gases,54 operating the detection system
in vacuum,55 and incorporation of enzymatic oxygen scavengers56,57 to reduce the
presence of molecular oxygen can help to reduce this effect.
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Another physical effect is optical saturation. The amount of photons emitted per
second scales linearly with the laser power as long as the saturation point is not
exceeded.58 However at optical saturation, the absorption cross section from the
molecule decreases such that further increases in laser power only generate more
background with no increase in the amount of emitted photons. The net effect of this is
a decrease in the SNR for the fluorescence measurement. It is also important to note
that the scattering signal is always linear with laser power; therefore, appropriate
conditions are required to balance the relationship between these factors in order to
maximize the fluorescence signal from single molecules.
1.2.4 The War Against Background Signal
A major challenge in designing single-molecule experiments is the ability to
conquer or reduce background signal. This is because almost all single-molecule
experiments are background limited. As noted previously, background signal may arise
as a result of residual fluorescence from the solvent system used, scattered radiations,
and/or residual emission from excitation sources that extend into the spectral range for
fluorescence detection especially when a diode laser is employed as the excitation
source.20 These sources of background, although critical, can be minimized by using
multiple filters and high quality optical components. Other sources, such as elastic
Rayleigh scattering from the sample itself as well as from its immediate environment
(e.g. backscattering from sample container) can be reduced through the use of
ultraclean, scratch-free substrates of the highest quality and interference filters.
Unfortunately, red-shifted Raman scattering from the host matrix and residual
fluorescence from impurities in the sample or host matrix provide a greater problem.
Both are proportional to the size of the probe volume, and though a logical step is to
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reduce the probe volume size as much as possible, impurities or molecular components
of the host matrix can generate very strong residual fluorescence. This problem is more
pronounced when working in the blue or ultra-violet spectral regions. It is therefore
paramount to use ultrapure solvents for samples to be interrogated. A prediction of the
possible emission wavelength of an unavoidable biological matrix may be helpful in
selecting the right fluorophore and optical filtering systems that will minimized the effect
especially when working in the UV region. Another method of overcoming this problem
is to work in the near infra-red spectral region where interference from unwanted
emissions is highly minimal.
1.3 Techniques: Instrumentation for SMD
Typical optical instruments used for single-molecule measurements are based on
three major experimental formats. These are confocal, scanning and wide-field
methods.59 Essentially, the optical configuration for each of these methods is aimed at
limiting the observed volume and carefully isolating the small number of photons
emitted by a single molecule. All emerging single molecule fluorescence techniques are
based on these methods which are considered in detail below.
1.3.1 Confocal Method for SMD
The observation volume in fluorescence measurements is drastically reduced
through the use of confocal optics, which allow for rejection of signal from above and
below the focal plane of a tightly focused excitation source. Figure 1.3a shows a
simplified schematic of a typical instrument used for confocal fluorescence detection.
Although this can also be configured in a trans-illumination format, the epi-fluorescence
(epi-illumination) format is the most common optical design for confocal microscopy and
this format has been described in detail in many reports.20,60-63 Essentially, a collimated
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laser beam is directed through a high numerical aperture (NA) microscope objective
using a dichroic beam splitter. This results in the generation of a focused diffraction
limited laser spot at the sample plane (see Figure 1.3b). All fluorophores within the laser
spot are excited and fluorescence emission as well as backscattered light from the
substrate and Raman scattering from the sample matrix are collected by the same
microscope objective, passed through the dichroic beam splitter and subsequently
through other appropriate emission filters to isolate the fluorescence emission of
interest, which is then focused on the detector (usually a single element detector such
as SPAD) through a pinhole aperture located on the optical plane of the emitted
fluorescence. The pinhole serves as a spatial filter that rejects out-of-focus light. This is
called the confocal advantage. It is important to note that the excitation volume is
defined by the size of the laser spot, therefore the use of high NA microscope
objectives, which generate small laser spot-sizes, helps in minimizing the observed
volume to improve the SNR in SMD by both increasing the signal (high collection
efficiency) and reducing background. A careful selection of the proper size pinhole is
very important in optimizing and isolating the single molecule fluorescence signal.
Although smaller pinholes are difficult to align, they give superior axial resolution.
Excellent treatment of pinhole selection has been given by Corle et al.64 The spatial size
of the fluorescence at the pinhole is simply determined by the diameter of the diffraction
limited laser spot multiplied by the magnification of the microscope objective. For
example, the spatial spread of the fluorescence collected from a laser spot size of 3 µm
using a 40x microscope objective would be ~120 µm. In this case, a pinhole with a
diameter of 80 µm will reduce the amount of fluorescence transmitted to the detector but
will give a better axial resolution. On the contrary, a pinhole with a diameter of 150 µm
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will transmit more fluorescence to the detector, but will generate poorly resolved signal
and high background. Therefore, a perfect correlation of this factor with the size of the
pinhole allows for better fluorescence transmission through the confocal aperture.
(a)

(b)

Figure 1.3. (a) A simplified schematic of confocal optics for single-molecule detection.
Adapted with permission from Tinnefeld et al.65 (b) A pictorial representation of the
focused laser spot produced by a confocal set up. The red spot represents the focal
volume.
1.3.2 Scanning Methods
The availability of highly accurate motorized stages that provide resolution down
to molecular sizes has created opportunities for fluorescence image acquisition using a
single element detector. The fluorescence image in this case is a reconstructed image
obtained by raster scanning the sample. There are basically two scanning methods
used for SMD. These are; confocal microscopy that utilize the confocal advantage (see
above) and near-field scanning optical microscopy (NSOM), which creates a laser spot
smaller than the diffraction limit.
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In confocal microscopy (confocal imaging), the instrumentation is similar to that
shown in Figure 1.3a except that in this case, a computer controlled motorized sample
stage is employed to facilitate the scanning. A typical single molecule image of a green
fluorescence protein (GFP) mutant 10c collected using confocal optics and stage
scanning is shown in Figure 1.4. The size of the fluorescence spots are about 500 nm in
diameter, which is determined by the optical resolution and not the size of the molecule.

Figure 1.4 Fluorescence image of a single GFP mutant 10c collected using confocal
scanning microscopy. Fluorescent spots are about 500 nm for each GFP molecule.
Adopted with permission. 66
NSOM is based on a simple principle.67,68

In this case, a highly localize

excitation is obtained using an optical fiber to create a relatively smaller laser spot. The
laser spot is generated from a narrow aperture produced by a modified optical fiber (see
Figure 1.5a). In early studies using NSOM, a single-mode optical fiber was heated and
pulled until it broke, forming a narrow tip that was much smaller than the original fiber
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core.69 The sides of the fiber are then coated with aluminum to form a waveguide for the
light travelling through the optical fiber with a tiny aperture, which is typically 70 - 80 nm
in diameter.70 Laser light is focused to enter the larger distal end of the fiber while the tip
of the fiber is positioned near the sample (~5 nm from the surface) using components
similar to those developed for probe techniques, such as atomic force microscopy
(AFM). While the fiber is located at a known distance from the sample, the stage is
scanned to create fluorescence images at the far-field end using traditional optics and a
single element detector. In this format, only a small region of the sample is excited,
thereby eliminating the need for a confocal aperture. Figure 1.5b shows a typical NSOM
image of single molecules of the dye, oxazine 720, in PMMA with fluorescent spots that
are below 100 nm in diameter. The spatial resolution in this image is not limited by the
optical resolution set by diffraction, but is determined by the diameter of the probing
fiber when in the near field with respect to the sample. NSOM has been used to reveal
heterogeneity among spectral properties of a single emitter as a function of time71 and
also to measure single-molecule fluorescence lifetimes.72 The major advantage of
NSOM includes the reduced sample volume offered by the extremely reduced laser
spot size, which generates low background counts and immediate orientation
information. Also, by monitoring the position of the scanned fiber tip, topographical
information can be obtained with the fluorescence image.20 However, this technique is
limited to flat samples because of the brittle nature of the fiber tip, which is susceptible
to breakage. Also, imaging single molecules far from the surface is impossible due to
the fact that the near field regime quickly disappears or disperses in the z-direction, thus
limiting the application of NSOM in many biological systems, such as the interior of a
cell. In addition, it is difficult to consistently make fibers with the same aperture size.
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Nonetheless, a potential solution to some of these limitations is the use of apertureless
NSOM techniques, which utilize ultrasharp tips as an antenna to localize the excitation
region.73

(a)

(b)

Figure 1.5 (a) Schematic representation of instrumentation used for NSOM. Adapted
with permission.65 (b) Single molecule image of Oxazine 720 molecules acquired with
NSOM, adapted with permission.74
1.3.3 Wide-Field Methods
Similar to traditional microscopy, wide-field methods for SMD utilize an excitation
source (usually a laser) to illuminate an area several microns in diameter. Fluorescence
emission from single molecules within the illuminated area are properly isolated and
passed to a two-dimensional array detector such as a CCD. Single-molecule studies
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performed in this fashion provide two major advantages: (a) simultaneous observation
of several individual chromophores and (b) the ability to monitor individual
chromophores at near video frame rates to allow for the observation of real time
translation of single molecules. However, wide field microscopy methods have a primary
limitation that stems from the fact that the maximum frame acquisition rates for CCD
cameras is much slower than the response time of single element detectors. This
limitation has been greatly curtailed with technology advancements in CCD designs,
which have made available ultrasensitive frame transfer electron multiplying CCDs
(EMCCDs) capable of generating amplified fluorescence signal through their intrinsic
signal cascade characteristics. Although, a large region of the sample is imaged onto
the detector’s active area, the ability to determine single molecule position is controlled
by the size of the CCD pixels and the total magnification of the optical system. Spatial
resolution is enhanced by dispersing the image over a greater number of CCD pixels by
using a CCD with smaller pixel sizes and a large pixel array. Because single molecule
photobleaching limits the total number of detected photons and one needs to collect
sufficient numbers of photons per pixel for a given integration time to be able to
maintain a reasonable SNR, appropriate magnification must be carefully selected in
designing the optics for wide-field imaging of single molecules. Although, CCD image
signal processing operations, such as binning, can assist in improving SNR when high
magnification and high NA microscope objectives are used, it does so at the expense of
spatial resolution.
There are basically two techniques for wide-field single molecule studies; these
are epi-fluorescence and total-internal reflection (TIR) microscopy. Implementations of
both techniques are discussed below.
28

1.3.3.1

Epi-Fluorescence Microscopy

Epi-fluorescence microscopy has been used for many years for biological
applications and was first applied to room temperature single-molecule experiments in
studying a biomolecular motor.42 A simplified schematic of the instrumentation used for
epi-fluorescence microscopy is shown in Figure 1.6. An approach for achieving wide
area illumination (excitation) is to use a non-collimated excitation beam, which is
focused on the back aperture of the microscope objective. The result is a collimated
output from the front aperture of the microscope objective with the field of illumination
determined by the size of the microscope’s aperture. An easy method of accomplishing
this is to use a lens with the appropriate focal length situated within the optical path of
the excitation light. A high NA microscope objective is usually employed to maximize the
detected fluorescence. Also, the flatness of field for the objective is an important
consideration in wide-field imaging, especially in situations that require careful
quantification of distance molecules across the image plane. Consequently, microscope
objectives with the highest flatness of field, such as those designated as “Plan Apo” or
“Plan Fluor” are typically used for wide-field imaging. Furthermore, it is very important
for the microscope objective to have very low residual fluorescence artifacts, especially
in the region of interest. The resulting single-molecule fluorescence is collected with the
same objective (epi-fluorescence) and carefully isolated using the appropriate optical
filters prior to being focused onto the CCD camera. Wide-field SMD has been applied in
the study of the motion of critical structures in single cell membranes75 and has also
been used to explore diffusion of single molecules of transmembrane proteins
embedded in live cells.76 Recently, the ability of wide-field SMD to monitor biochemical
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reactions was demonstrated in studying thermal denaturation and the melting profile of
labeled DNA molecules in a FRET assay.77

Figure 1.6 Schematic of epi-fluorescence optics; objective (O), dichroic filter (D),
emission filter (F). Adopted with permission.20
1.3.3.2

Total-Internal Reflection (TIR) Fluorescence Microscopy

TIR fluorescence measurements utilize the exponential decay of an evanescent
field generated at a high-index to low-index boundary when light is incident on a lowindex medium from a high index material at an angle greater than the critical angle (the
angle at which total-internal reflection occurs). The decaying evanescent field
penetrates into the low-index medium to a small distance often referred to as the
penetration depth. This distance is typically ~150 nm for green laser excitation, which
implies that only fluorophores that are sufficiently close to the boundary will be excited
while those further away in the bulk sample will not be excited. As a result, only a very
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small volume of the sample is observed. Implementation of TIR fluorescence for SMD
can be achieved using a prism that is coupled to a microscope cover glass or a thin
glass substrate (or any other suitable substrate of high refractive index) using index
matching oil. TIR is achieved when the laser beam is launched into the prism above the
critical angle, which generates an evanescent field at the interface.78 A schematic
drawing of a prism-type TIR set-up used for imaging single dyes79 and single GFPs80 is
shown in Figure 1.7a.
Another method by which TIR is implemented for SMD is to couple the input
laser beam through the edge of a high NA microscope objective such that illumination
occurs around the sides of the glass-water interface, where the launch angle is above
the critical angle. This creates an evanescent field that excites a thin plane of the
sample near the interface. This method was first implemented by Funatsu et al.42 and is
called through the objective TIR.81 This is represented in Figure 1.7b.
An optical fiber has also been used to generate evanescent field excitation
through TIR. In this case, a section of the core of the optical fiber is exposed to the
fluorophore such that when light is coupled into the optical fiber, the evanescence wave
field generated on the core surface is used to excite the fluorophore in close proximity to
the fiber surface. A simplified set up for this technique is represented using the
schematic diagram shown in Figure 1.7c.82
A typical image acquired using TIR optics is shown in Figure 1.8. This image was
obtained using the prism-type TIR configuration. Note also that this is one method by
which single molecule fluorescence data is displayed for easy comparison of the relative
intensities of individual molecules. Due to the low background of this image, information,
such as molecular diffusion, can easily be extracted.
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(a)

(b)

(c)

Figure 1.7 (a) Schematic diagram of a prism-type TIR experiment. Adapted with
permission.22 (b) Schematic diagram of an objective-type TIR; adapted with
permission.20 (c) Excitation through an optical fiber; adapted with permission.82
1.3.4 Detectors for SMD
The ability to detect single-molecule fluorescence depends not only on the optical
design of the detection system but also on the efficiency of the readout device. Such
devices should generate minimal dark noise and posses high quantum efficiency to be
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Figure 1.8 A typical single molecule image of GFP mutant T203Y acquired with a CCD
using TIR fluorescence; adapted with permission.66
able to register fluorescence signals from single molecules. Thus, an important
consideration in designing the instrumentation for single molecule experiments is the
selection of an appropriate readout device with a matching capability for the particular
single-molecule experiment format. Detectors for SMD are classified into two groups:
single element detectors and two-dimensional array detectors. Each of these classes of
detectors has unique capabilities and characteristics for different experimental
approaches. While single element detectors are mainly used for point-by-point
fluorescence detection (e.g. in confocal methods and scanning methods), twodimensional array detectors are used for wide-field microscopy.
1.3.4.1

Single Element Detectors

Early single-molecule experiments utilized photomultiplier tubes (PMTs) to
register fluorescence from single molecules diffusing through a tightly focused laser
spot.13 PMTs have large active areas (photocathode), which can be greater than a
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square centimeter, and are generally able to multiply single photon events by a millionfold while at the same time offering suitable temporal response with low dark noise
levels when cooled. However, they typically have low quantum efficiencies (about 20%),
which further decreases at longer wavelengths thus limiting their use in SMD for
extended-red fluorophores. Also PMTs require high voltages to operate and have
several pieces of electronic components for single photon counting, which makes the
design a little complex.
A more simple and generally preferred detector for single-molecule fluorescence
is single photon avalanche photodiodes (SPADs), which offer several advantages
compared to PMTs. SPADs are available in small integrated packages with on-board
amplification and requires only ~5 V to operate. SPADs have quantum efficiencies
greater than 60% in the visible region of the electromagnetic spectrum with up to 90% in
the near-infrared (NIR). Generally with SPADs, a detected photon is converted to a
digital output pulse, which is counted using a computer-based digital acquisition
board.83 SPADs also have low dark count rates (25 – 100 cps) comparable to the best
cooled PMT. The only disadvantage of SPADs compared to PMTs is the small active
area of the SPAD (~200 µm in diameter), which creates a challenge in the design of a
typical fluorometer since most of the collected photons could fall on the non-active
regions of the SPAD and thus will not be detected. However, this limitation becomes an
advantage in confocal imaging where the small active area can be used as a confocal
aperture to improve the signal quality.
1.3.4.2

Two-Dimensional Array Detectors

Wide-field methods for SMD employ array detectors, such as microchannel
plates or CCDs. The microchannel plate detector is a large area PMT that is configured
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to register fluorescence signal in two dimensional x-y formats. Although this detector
can provide fast timing information, it has a low quantum efficiency, comparable to that
of a conventional PMT. The detector of choice for wide-field microscopy is the CCD,
due to its intrinsically high single photon detection efficiency with low read noise. A
CCD contains an array of pixels, each of which acts like an individual detector84 and
makes it possible to register multiple isolated fluorescent signals on a single CCD chip.
Back-illuminated CCD cameras have been used in astronomy and spectroscopy.
This type of CCD camera has high quantum efficiency ranging from 70 – 80% in the red
and infrared regions and they are built with liquid nitrogen cooling to operate at ~120oC
to reduce dark counts down to the level of 1 electron/pixel/h. However, these detectors
are limited by their characteristic read noise (~20 electrons for each analog-to-digital
conversion) and operate with low speed. Consequently, they are best used in situations
that allow long signal averaging times.
Another generation of CCD is the intensified frame transfer CCD cameras, which
are designed with optical integration using a photocathode, fiber bundle, microchannel
plate, phosphor screen, and Si CCD chip. Photons are first detected by the
photocathode, and the emitted electrons are amplified in the microchannel plate that is
coupled to the photocathode using a fiber bundle. Subsequently, the phosphor screen
generates photons from the amplified electrons, which are converted back to electrons
by a front-illuminated Si CCD detector. A fast analog-to-digital converter (ADC) is used
to generate digital numbers from the electrons in each CCD well. The advantage of this
design is the ability to multiply the detected photoelectrons prior to readout and
continuous readout provided by the frame-transfer mode. In the frame transfer mode,
the entire frame of the CCD is transferred to a non-photosensitive area following each
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exposure. Also the use of a fast ADC allows these detectors to operate at high frame
rates (near video frame rates) without sacrificing single photon detection efficiencies.
While these detectors provide for high speed imaging, they are characterized by a low
quantum efficiency, excess noise from the multiplication process and non-uniform gain
over the microchannel plate.
The back-illuminated frame-transfer CCD camera is another class of detectors
designed with fast ADC capabilities that operate without large increases in read noise.
This design provides for uniform sensitivity from pixel-to-pixel and retains the high
quantum efficiency of back-illuminated CCDs.84
Further developments in CCD technology have recently made available ultrasensitive frame-transfer CCDs designed with on-chip multiplication gain. In this design,
the last row of the CCD wells is connected to a series of additional wells such that
secondary emission is generated as the electrons are passed from well-to-well. This
can result in a multiplication gain of ~1000 depending on the number of pixels in the
serial register. This detector is finding wide spread applications in SMD with a major
advantage of signal amplification, reduced read noise and continuous imaging at video
frame rates.
1.3.5 SMD Data Analysis
Single-molecule fluorescence is governed by photon statistical models,85-88 which
allows for the derivation of experimentally measurable characteristics of interest such as
the autocorrelation function or photon burst distribution.89
SMD experiments are usually characterized by low SNR, thus creating a challenge
in the ability to clearly distinguish background noise from single-molecule signal as well
as distinguishing different molecules by their emitted photons. The autocorrelation
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function has been shown to be a useful tool for dissecting the average motion of small
molecules.13,89 It has also been demonstrated as a sensitive indicator of fluorescence
signal produced by individual molecules as they traverse through a focused laser
beam.13,14 For a data set d(t) consisting of N consecutive values of the number of
photons detected in a specific time interval ()ז, the digital autocorrelation function A( )זis
given by:13,14

(1.1)
Where d(t +  )זrepresents the data point (value) at time t + ז. A plot of the function A ()ז
for a given experimental data set would generate a peak, which is easily distinguishable
from background signals. The autocorrelation peak is an indicator of the presence of
molecular species in the probe volume. In the absence of emitting species in probe
volume, the peak disappears. This is because the random noise of the background is
not recognized by the autocorrelation function. The width of the autocorrelation peak is
a measure of the time a dye molecule stays in the probe volume (molecular transit
time). It can be used to discriminate different molecular species based on their transit
time. The autocorrelation function will indicate that a high sensitivity (molecular level) is
achieved in the experimental measurement. However, this type of analysis is not able to
identify single molecules as they migrate through the excitation volume.
A more quantitative approach for identifying the passage of individual molecules
through an illuminated volume element is the use of the weighted quadratic sum
(WQS);13,14,90

(1.2)
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where k is the approximate time interval representing the lower limit of the molecular
transit time or the average photobleaching lifetime of the dye molecule, and ω( )זis a
weighting function chosen to best distinguish the single molecule signal from
background fluctuations. Usually ω( )זis chosen to compensate for the time interval
between when the molecules approach the excitation volume and the photobleaching
lifetime of the molecule (sometimes, ω( )זrepresents a Gaussian). For the WQS, S(t) will
have a sharp maximum whenever emitting dye molecules flow through the laser such
that when a threshold value Sth is set, the data set is sufficiently filtered from
background interference. In other words, a signal S can be clearly identified as a single
molecule signal when S(t) > Sth . This quantitative information can be used to calculate
the detection efficiency (DE) of the detection system by using;
DE = Md/Men

(1.3)

where Md is the number of molecules detected and Men is the number of molecules that
enter the detection volume.
The maximum-likelihood criterion (MLC) is another tool, which can be used to
process single-molecule data.90 This is based on a probability distribution of background
noise and single-molecule signal.91 For a given data set N, the probability that N
represents single-molecule events (Pmol) and the probability that N represents
background fluctuations (Pnoise) both are calculated and fitted into the MLC function
(M):90

(1.4)
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M > 0 = molecule present
M < 0 = no molecule present
The MLC simply states that the process with the highest probability is the most likely.
1.3.6 High Throughput SMD
The advent of wide-field imaging and improved technology in CCD design (see
section 1.3.3) has created an opportunity for throughput enhancement in single
molecule experiments. This allows for the simultaneous study of several surface bound
single molecules92 and monitoring of molecular motion in solution.93,94 Also,
advancements in micro-total analysis systems (µ-TAS)95 has enabled parallelization of
SMD experiments, which has allowed maximizing throughput via parallel multi-sample
processing in short analysis times.
1.4 Merging Microfluidics with SMD
Microfluidics can be defined as the technology of systems capable of processing
and manipulating minute amounts of fluid (liquid samples) using micrometer-scale
channels. These systems or devices consist of microfabricated structures, which can be
designed to produce diagnostically useful systems (e.g micro-total analysis system, µTAS) for such applications as point-of-care (POC) measurements.95-98 There has been a
rapid growth and wide spread applications of microfluidic technology since the
conceptualization of miniaturized chemical analysis systems in the early 1990s.99,100
Presently, it is adopted in various fields of applied research, such as DNA
sequencing,101,102 immunoassays,103 protein analyses,104 and clinical diagnostics.105
Microfluidic-based

systems

possess

unique

advantages,

such

as

sample

miniaturization, reductions in reagent consumption, short analysis times and the ability
to integrate several processing steps into a single system, which simplifies routine
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operations and also eliminates sample cross contamination. In addition, these devices
are viable platforms for parallel processing of multiple assays (High Throughput
Screening, HTS) due to the inherent ability to generate multiple fluidic processors over
small footprints suitable for optical imaging.106-108 Other benefits include the ability to
automate fluid handling and drastically reduce assay cost.
While microfluidic channels provide the interface required to handle small sample
volumes, SMD allows for the localization, counting, and identification of individual
molecules present in the small volume. Thus, by merging microfluidic technology with
SMD, the optimal requirement for the analysis and manipulation of samples on a singlemolecule scale can be achieved; such merger would facilitate system integration and
automation suitable for increasing throughput in biochemical screening such as HTS in
drug discovery.108 In more specific terms, SMD in combination with microfluidics offers
new tools for research; First, single-molecule analysis permits a reduction in the number
of molecules needed per assay, thus the total sample volume and the sample
concentration can be drastically decreased. This is particularly important when dealing
with such systems as biological cells that have few copies of target analytes. Second,
the identification of single molecules greatly reduces the time required for data
acquisition; consequently miniaturized samples are analyzed with increased speed and
high statistical accuracy. Third, mixtures of analytes can be analyzed in a flow-based
format with higher molecular detection efficiency by employing distinct identification tags
(multiplex single-molecule detection). Fourth, the ability to carry out multiple assays in
parallel with single-molecule sensitivity (high throughput SMD).
Silicon and glass have been traditionally employed for creating microfluidic
devices109, 110 based on fabrication techniques developed in the microelectronics sector.
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Successful fabrication on these substrates has been accomplished using several
methods such as lithography, plasma etching or reactive-ion etching techniques.111,112
The attractiveness of glass and quartz as classic materials for microfluidic applications
includes their well-defined surface chemistry, good electro-osmotic properties and
excellent optical properties, which are suitable for fluorescence measurements.
However, the fabrication modalities are quite challenging and relatively expensive. This
result into a search for alternative materials, that are more conducive to large-scale
production.
1.4.1 Polymers as Fluidic Chip Substrate for SMD
Polymer materials offer important advantages in microfluidic device production.
This is essentially due to their wide range of material properties, which can be selected
for diverse applications. In addition, they are generally low-cost materials with good
processibility requiring simple fabrication procedures to make devices allowing for the
inexpensive replication of microstructures and the mass production of disposable
microchips.113 However, many polymers display poor optical properties that may not be
conducive to ultra-sensitive fluorescence measurements required for SMD and thus, a
careful selection of a suitable polymer for microfluidic construction must be made based
on their properties to ensure high performance for the intended application.113-116 For
SMD, properties that are of fundamental importance include the optical transparency,
autofluorescence levels, biocompatibility and chemical resistance. Other properties
such as the glass transition temperature, machinability, tensile strength and thermal
conductivity are important in selecting the appropriate material. A compilation of
physical and chemical properties of the most widely used polymers for microfluidics
applications is shown in Table 1.1 (adopted from Becker et al. 115).
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1.4.2 Microfabrication Techniques
Fabrication of the desired fluidic structures on polymers for SMD can be
achieved by several methods including lithography, UV-laser ablation, hot embossing,
injection molding, direct micromilling, or soft lithography. Detailed descriptions of these
methods can be found in selected reviews.117-120 However, a brief description of LiGA is
given below;121,122
1.4.2.1

LiGA

A common approach for large –scale production of microfluidic devices using a
polymer substrate is LiGA; a German acronym for lithography, electroplating and
molding. This process is normally employed to fabricate high quality mold inserts for
mass production of polymer parts (microfluidic devices). It employs either a synchrotron
source (X-ray LiGA) or UV light (UV-LiGA) as appropriate for a particular microfluidic
design.123 In X-ray LiGA,124 an X-ray sensitive resist, such as PMMA, is coated on a
plating base (e.g. stainless steel), which is then exposed to X-rays to form
microstructures using an appropriate X-ray mask that has the defined pattern. The
exposed photoresist is then removed in a developing step using a GG developer (a
mixture

of

water,

2-(2-butoxyethoxy)ethanol,

tetrahydro-1,4-oxazine

and

2-

aminoethanol),125 which is a solvent that dissolves the exposed portion of the resist.
Following this step is an electroplating process that fills up the voids between the
polymeric features with metal (usually Ni), which is deposited over the top of the
patterned resist to a thickness of ~5 mm to obtain a metal mold. A schematic of the
LiGA processing steps using X-ray photopatterning is shown in Figure 1.9. After the
electroplating process, the polymeric resist is removed to generate the metal mold
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Table 1.1 Physical and chemical properties of most widely used polymers for microfluidic applications.
Adopted from Becker et al.

master, which can be used to replicate polymer microstructures repeatedly through
injection molding or hot embossing.
UV-LiGA operates with the same principle except that a UV light source is used
instead of X-rays.126,127 This approach has been used to produce high aspect ratio
patterns using SU-8 as the resist.128
1.4.2.2

Hot Embossing

This is a replication technology used to transfer fluidic patterns from a mold
master into the required polymer substrate.129,130 The pattern on the mold master can be
made either by micromachining131,132 or by a lithography-based approach such as LiGA.
Hot embossing is done in three steps; first, the suitable polymer material is placed
between two metal plates (one contains the mold master) and heated to above its glass
transition temperature (Tg). Second, a controlled force is then applied onto the soften
polymer by pressing the heated mold master under vacuum for few minutes. Third, the
metal plate and polymer substrate are cooled below the Tg of the polymer prior to the
withdrawal of the metal plates to form the desired pattern in the polymer. This technique
is very simple and cost effective. It has a fast processing time of ~5 mins and can be
used to produce thousands of parts from a single mold master. Examples of parts
fabricated using this technology are shown in Figure 1.9
1.4.2.3

Thermal Annealing

Following the transfer of the fluidic pattern into the polymer substrate as
described above, the next step is the creation of the fluidic channels. This is mostly
done by thermal annealing. In this process, a thin polymer sheet, often referred to as
cover sheet, which should be of the same (or similar) material properties (especially the
glass transition temperature, Tg) as the substrate bearing the fluidic pattern, is used to
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enclose the fluidic pattern by thermally bonding it to the substrate to create the fluidic
channels. Thermal annealing proceeds in four steps: (1) the thin polymer sheet is cut to

Figure 1.9 X-ray LiGA processing steps for making a metal mold master and molding
on polymer substrates. The process begins with a lithography step using X-ray mask
and a photoresist to create the desired pattern. After development, the voids left by the
resist are filled with metal in the electroplating step to create the desired structures on a
metal mold which is then used for molding by transferring the structures on the mold to
the polymer substrate. Scanning electron micrograph of metal mold and polymer parts
produced with this process are also shown. Adopted with permission.121,133
the appropriate size and placed on the polymer substrate containing the fluidic patterns
to enclose the patterns; (2) the assembly is sandwiched between glass plates and
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clamped together; (3) heat is applied, usually in a temperature controlled oven to raise
the temperature to slightly above the Tg of the polymer substrate for a reasonable length
of time; (4) the assembly is allowed to cool to room temperature to generate the fluidic
chip.
1.4.3 Single Channel SMD
Most flow-based single-molecule experiments are performed in a single fluidic
channel using confocal optics (see section 1.3.1) and single element detectors such as
a SPAD (see section 1.3.4.1). In this format, the fluidic channels provide for a conducive
environment for effective sample manipulation and delivery while the single element
detector and confocal configuration provide for a high sampling rate (defined by the
response time of the detector) and high sensitivity. The sampling rate simply represents
the frequency of data collection by the detector. For example, if a target analyte (or
molecule) traversed the probe volume with a transit time of 1 s, a detector element with
a respose time of 0.1 s will generate 10 data points (i.e. 10 data points per second) for
the analyte signal to represent a Gaussian peak.134-139 While this format generates high
detection efficiency, which is simply the percentage of molecules detected above a
threshold value, and favorable SNR, it is characterized with a low sample processing
throughput.140 The throughput limitation associated with single channel SMD is
addressed using a multichannel configuration and a suitable detection system for
parallel readout of results.
1.4.4 Multi-Channel SMD
In multi-channel single-molecule experiments, the samples are dynamically
transported through a series of fluidic channels and single molecules are interrogated
using wide-field illumination (see section 1.3.3). The resulting fluorescence signals from
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flowing molecules in the fluidic channels are imaged onto an array detector, such as a
CCD for parallel readout. In this configuration, the increase in throughput is directly
related to the number of channels patterned onto the fluidic substrate that are
interrogated. The potential of this experimental format for drastic reductions in sample
processing times suitable for high throughput biochemical analysis has been
demonstrated in recent reports.77,141
There are basically two methods for excitation to perform high throughput singlemolecule experiments in a multi-channel fashion: epi-illumination and waveguide
excitation (see section 1.3.3.1). In epi-illumination for multi-channel SMD,77 the fluidic
channels must be configured in a high packing density format and confined within the
excitation volume, which is defined by the optical design, such that molecules traversing
each fluidic channel can be identified via optical imaging. The fluidic channels should
also be constructed with the appropriate dimensions to minimize background
fluorescence from the sample matrix.
Waveguide excitation possesses the potential for improved sensitivity since it
utilizes a confined evanescent field with a small penetration depth (~350 nm) and thus
generates ultra-small probe volumes suitable for maximizing the single-molecule
fluorescent signal. However, the challenge in this technology lies on the ability to
fabricate an integrated system with a fluidic network and waveguide suitable for multichannel flow-based SMD. This configuration was recently reported by Soper’s group,142
which employed two different substrates to create a fluidic system with integrated
orthogonal waveguide for high throughput fluorescence measurements. Exploitation of
this technology could expand the use of single-molecule fluorescence especially in high
throughput biochemical screening applications.
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1.4.5 CCD Operational Formats for Multi-Channel SMD
CCD detection technology allows for different software-controlled operational
modes suitable for single molecule studies in biochemical assays. The traditional
operational mode of CCDs is the snap-shot mode, where a CCD image is taken and
processed before the next image is captured. This is generally characterized by a low
duty cycle, which in this case depends on the total integration time for an image. The
ability to track single molecules with 100% duty cycle in multi-channel SMD applications
has been demonstrated by operating the CCD in a time-delayed integration (TDI)
mode141 or in frame transfer mode (FTM). 77
1.4.6 Time-Delayed Integration (TDI) Mode
In this mode of operation, the CCD pixels of the array are exposed for the entire
duration of an experiment to continuously collect fluorescence signals from flowing
single molecules. The CCD chip is configured using the interface software to read out
one row at a time instead of the entire chip. The parallel shift of the CCD is then
synchronized with the linear velocity of the flowing single molecule so that
photogenerated signal is collected into the same potential well of the CCD array thereby
enhancing the SNR while at the same time increasing the duty cycle of the detection
system. In this case, the SNR scales with N1/2, where N is the number of rows in the
CCD camera. A more detailed description of the TDI mode can be found in Emory et
al.141
1.4.7 Frame Transfer Mode (FTM)
The FTM allows for continuous imaging with 100% duty cycle to track
fluorescently labeled molecules at near video frame rates as the molecules traverse an
interrogation zone. Frame transfer CCDs are constructed with the CCD chip divided into
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two halves: a photosensitive area and a non-photosensitive (image storage) area. Once
an image is taken, it is immediately transferred from the sensor area to the frame
transfer area and immediately followed by another image being collected while at the
same time, the stored image is being read out through the serial register. This allows for
high speed imaging and it is suitable for monitoring molecular motion in fluidic systems.
A schematic representation of a frame transfer CCD chip is shown in Figure 1.10.
Another added feature to most frame transfer CCDs, especially the EMCCDs, is on-chip
multiplication gain, which provide for single-molecule sensitivity. The on-chip gain is a
signal boosting process that multiplies photo-generated charges above the read noise
and occurs before the charges reach the readout amplifier. This process can generate
gain factors greater than 1000x. The technology employs an extended serial register
called a multiplication register (see Figure 1.10), where electrons are multiplied via
impact ionization that is initiated and sustained by applying higher than typical CCD
clock voltages (up to 50 V). For most cascade CCDs, the clock voltage is controlled by
a 12-bit analog-to-digital (ADC) converter. This technology provides for single-molecule
sensitivity even at supravideo frame rates.
1.5 Biochemical Applications of SMD
A new environment for biochemical research has been realized by emerging
SMD techniques. In its present status, SMD has provided unprecedented insight toward
the understanding of functional details in many biological areas such as molecular
motors,21,143-145 nucleic acid enzymes,146-148 RNA activities,149-152 protein folding,153-156
enzymology,157-162

gene

expression,26,163

and

mutational

analysis.164

Detailed

discussions on these and other applications can be found in selected reviews.22,65,165-175
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Figure 1.10 A schematic representation of a frame transfer CCD chip with on-chip
multiplication gain. Images are taken with the sensor area and immediately transferred
to the frame transfer area. Prior to being read out, the collected charges that form the
image are multiplied many times in the multiplication register to enhance sensitivity.
However, specific examples are given below, which are related to two commonly
applied assay format for HTS: receptor binding assays and competition- / inhibitionbased assays.
1.5.1 Protein Kinase Assay
SMD technology can be readily applied to kinase-type assays to generate high
quality data such as molecular distribution of phosphorylated products. A typical
example representing an indirect competition-based assay format is given in Figure
1.11, which shows components in a kinase inhibition assay. In this illustration, the
production of phosphorylated product is measured using the change in polarization as a
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result of the displacement of a fluoro-labeled pre-phosphorylated peptide from the
specific antibody.176 This has been demonstrated at Pfizer Sandwich using the first
generation EVOscreen Mark-II technology173 to measure molecular brightness in each
polarization direction in a kinase screening assay. In this screening platform, high
quality measurements of fluorescence polarization were demonstrated using single
molecule detection in a 1 µL volume of the assay.176

Figure 1.11 Components in a kinase inhibition assay using antibody recognition.
The phosphorylated product displaces a pre-phosphorylated fluoro-labeled reporter
peptide from the antibody. 1: non-phosphorylated petide substrate, 2:
phosphorylated peptide product, 3: pre-phosphorylated fluoro-labeled reporter
peptide. Molecular brightness in each polarization direction arising from the free and
antibody-bound state can be measured. Adapted with permission.176
1.5.2 Membrane Receptor-Ligand Assay
The binding of a fluoro-ligand to a sub-cellular component such as a receptor in a
membrane preparation will generate two distinct fluorescent species due to the high
local concentration of the membrane receptor. The two fluorescent species represent
the free ligand and the ligand bound to the receptor (see Figure 1.12). Introduction of
test compounds into the assay will lead to competitive binding of the test compound and
the labeled ligand with the receptor. SMD detection technology can then be used to
construct fluorescence intensity distributions of the different species in the assay to
determine both the degree of binding and the populations of free and membrane-bound
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ligand. This has been implemented using the second generation Evotec screening
system (EVOscreen Mark-III) in a vesicle-based assay.177 The assay was configured by
preparing vesicles from cells containing the β2 adrenergic receptor and employing a
Rhodamine Green-labeled ligand (CGP12177A).178 Binding interactions of ligands to
vesicles were monitored, which allowed quantification of bound and unbound ligands
using fluorescent intensity distribution analysis (FIDA).179,180

Figure 1.12 Schematic representation of a receptor binding assay showing the
principle assay components. 1: free ligand, 2: autofluorescent compound, 3:
membrane associated receptor/ligand complex. Adapted with permission.176
1.5.3 Future Perspective
SMD technologies have evolved to provide previously unattainable wealth of
molecular information in biochemical assays. Besides the ability to distinguish different
fluorescing species, such as bound and unbound labeled molecule in one sample, the
techniques also provide for the ability to measure multiple, species-resolved
parameters. For example, molecular counts, size and brightness can be measured
simultaneously, which are useful parameters that can be used to clearly distinguish real
hits from false positives in drug screening. In addition, artifacts induced by autofluorescent compounds, biological reagents as well as technical errors can be clearly
discriminated when analyzing SMD data, which will facilitate the drug validation process
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by ensuring that drug candidates for clinical trial have reasonable potency for the target.
The technology is currently driving drug discovery research to higher throughputs
especially the high sensitivity advantage, which is a major challenge in miniaturized
HTS. A combination of SMD with microfluidics will govern and lead the future of drug
discovery.
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CHAPTER 2
HIGH THROUGHPUT SINGLE MOLECULE DETECTION FOR MONITORING
BIOCHEMICAL REACTIONS*
2.1 Introduction
The ability to process large amounts of information for high throughput
applications has become a primary ambition due in part to the large number of samples
that must be interrogated and the complexity of those samples. An example where high
throughput data processing is significant is in the drug discovery pipeline (i.e., high
throughput screening) where combinatorial libraries consisting of millions of potential
small molecule drug candidates are screened for their interaction with therapeutic
targets using fluorescence spectroscopy as the readout modality.1-6
An approach toward increasing the data production rate for processing
biochemical reactions is to increase the number of reactions run in parallel, which
allows for analyzing a large number of targets simultaneously. This parallel processing
is commonly carried out in titer plates, with increases in the well density used to
increase data throughput. For example, titer plates can be configured to run 96 to 9,600
reactions in parallel on a 3” x 5” plate.7,

8

With increases in well density also comes

reductions in well volume, placing severe demands on the readout hardware to provide
parallel detection to further increase throughput while at the same time providing high
detection sensitivity and favorable limits of detection in spite of the reduced well volume.
Other applications that require the ability to transduce large numbers of targets quickly
include capillary array electrophoresis,9 DNA microarrays,10 small-molecule arrays,11, 12
and protein microarrays.13 In addition, micro-Total Analysis Systems (µ-TAS) have been
employed as a tool for increasing throughput in many applications due to their exquisite
*Reprinted by permission of RSC.
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characteristics conducive to high sampling rates brought about by reductions in analysis
times and the parallelization of processing units. 14-17
Another analytical technology, which facilitates the realization of high throughput
biochemical data processing, is single molecule detection (SMD). SMD provides the
ability to eliminate many sample processing steps associated with multi-step assays,
significantly reducing assay time. This has recently been demonstrated by Wabuyele et
al., where the overhead processing time associated with PCR amplification of target
DNAs was eliminated by detecting single nucleotide polymorphisms (SNPs) in genomic
DNA using single-pair FRET (spFRET).18 Using spFRET, the authors were able to
detect SNPs in a processing time less than 5 min. Another advantage of SMD is the
detailed information revealed when monitoring biochemical reactions. For example, it
can yield insight into complex fluctuation phenomena and hidden heterogeneity that
cannot be observed in ensemble techniques.19
However, the challenge associated with many SMD assays is their intrinsic low
throughput, especially for flow-based SMD experiments where a laser focused to a
diffraction limited spot is used to interrogate material as it traverses through the
excitation volume.20,

21

To realize the full processing potential of SMD for high

throughput applications, the readout hardware needs to be configured in a parallel
format without sacrificing sensitivity.
The common approach for realizing high single molecule sensitivity is, as stated
above, the utilization of ultra-small probe volumes, which reduces background
interferences resulting from the sample matrix emanating from autofluorescence or
scattering.22,

23

A common method for achieving ultra-small probe volumes is the use of

confocal optics,24-27 in which the laser beam is focused to a diffraction-limited area
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producing sampling volumes in the sub-picoliter regime. However, these confocal
sampling volumes are usually designed with single element detectors and thus,
generate small sample processing throughput rates.
This limitation can be addressed by operating the readout system in a multichannel configuration, such that single molecules are transported through a series of
fluidic processors that are interrogated using wide-field illumination with the resulting
fluorescence imaged onto an array detector for parallel readout. An array detector that
can be employed for fluorescence imaging appropriate for single molecule high
throughput processing is the charge coupled device (CCD).28 Advancements in CCD
technology has made available ultra-sensitive cameras appropriate for realizing
detection of single fluorescence molecules in flow-based measurements where the
signal is transitory in nature.29-32

For example, Soper and coworkers33 recently

described a CCD-based single molecule analysis system in which a flowing sample
composed of double stranded DNA molecules labeled with an intercalating dye (TOTO3) were imaged onto a 1340 x 100 pixel CCD camera operated in a time-delayed
integration (TDI) mode.33 The TDI mode was used to collect photo-generated signal
from single multiply-labeled DNA molecules into a potential well of the CCD array as the
molecules traversed the field-of-view (FoV), thereby enhancing the SNR at the same
time increasing the duty cycle of the detection system.

Van Orden et al. also

demonstrated the ability to image single DNA molecules labeled with an intercalating
dye using a CCD operated in a snap-shot mode.34
While the aforementioned works are excellent examples of increasing the sample
throughput for flow-based SMD experiments, the limitations are that the single
molecules were double-stranded DNAs loaded with multiple flours. In the case of λ-DNA
65

(~48,500 bp), each DNA molecule had a load of approximately 9,700 dye molecules.
Therefore, high throughput flow-based SMD systems have yet to demonstrate the ability
to detect single fluorophore molecules.
Another viable operational modality for a CCD camera directed toward SMD is
the frame transfer mode (FTM), which allows for high speed imaging.35, 36 For example,
Li and Yeung utilized a frame transfer electron amplifying CCD to monitor dynamic
conformational changes of flavin adenine dinucleotides in different media on a cover slip
in which the molecules were immobile. Their results demonstrated the ability to monitor
the real-time dynamics of the photoproduct formation between FAD molecules at the
single molecule level.37
The availability of FTM CCDs with on-chip gain has created the capability to
study biochemical reactions at the single molecule level utilizing flow-based
measurements in which the single molecules are dynamically transported through the
illumination zone. These electron multiplying CCDs (EMCCDs) are equipped with a full
frame storage region and a charge multiplication register that generates secondary
electrons via an impact-ionization process. The net gain on these cameras can be
greater than 1000-fold. Although, the resulting gain has a complex relationship with the
applied voltage, it can be estimated using the expression;
G = (1+g) N

(2.1)

where G is the gain factor, g is the probability of generating secondary electrons in the
multiplication register (typical value range from 0.01 to 0.016), and N is the number of
pixels in the multiplication register. Thus, even with a fairly low probability of generating
secondary electrons in the multiplication register, the cascade effect over the large
number of stages is quite high. For example, a CCD with N equal to 500 and g = 0.012,
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will produce an on-chip gain of ~389. The resulting signal (St), defined by the number of
photoelectrons generated in each pixel, can be estimated using the following
expression;
St = S*QE*G

(2.2)

where S is the number of incident photons impinging on a pixel, QE is the quantum
efficiency at the wavelength being monitored and G is the EMCCD gain (see eq. 2.1).
The FTM allows continuous imaging with nearly 100% duty cycle and can track
fluorescently labeled molecules at near video frame rates as they traverse through an
interrogation zone while the on-chip gain provides adequate sensitivity for single
fluorophore detection.
In this Chapter, we combined the advantages of microfluidics with a wide field
fluorescence imaging system and present, for the first time, the ability to detect single
chromophore molecules in a multi-channel flow-through configuration and monitor
biochemical reactions at the single molecule/fluorophore level. The system reported
herein provides high throughput single molecule processing capabilities using an ultrasensitive epi-fluorescence imaging system consisting of a FTM EMCCD with on-chip
multiplication gain. The system possessed a large FoV (200 µm, diameter, generated by
a 40x/0.75 microscope objective) capable of imaging a series of parallel fluidic channels
simultaneously. As an example of the utility of this system to monitor biomolecular
reactions at the single molecule level at relatively high processing rates, a melt analysis
of double-stranded DNA (dsDNA) using a resonance energy transfer reporting system
was used. The dsDNA contained a construct labeled on the 5’-end of the sense strand
with a dye and a quencher on the 3’ end of the anti-sense strand. The number of photon
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burst events arising from melted duplexes at different temperatures could be used to
determine the melt profile of this double-stranded complex.
2.2 Experimental Details
2.2.1 Optical System
The optical set-up for the flow-based multi-channel SMD is shown in Figure 2.1a. An
HL6535MG laser diode (Thorlabs, Newton, NJ, USA) provided excitation (660 nm) with
a peak power of 30 mW. The laser diode was mounted on a LDM21 (Thorlabs) laser
mount connected to a laser driver (LDC 205, Thorlabs) and a temperature controller unit
(TED 200, Thorlabs). The laser output was collimated using an aspheric lens (C230TMB, Thorlabs) and passed through a 660 nm laser line filter (660DF10, Omega Optical,
Brattleboro, VT, USA) that was placed in the optical path of the excitation source. A
dichroic mirror was used to direct the laser into a microscope objective (40x, 10x or 5x,
Zeiss, Thornwood, NY, USA) and then, onto the sample after being shaped using a
plano-convex lens (LA1509, Focal length = 100 mm, Thorlabs). The shaping lens was
used to generate a collimated light output from the objective

with a diameter

determined by the aperture of the objective; the diameter of the collimated light, which
determined the FoV of the imaging system, was different for each microscope objective
used in our experiments (0.2 mm for a 40x, NA = 0.75 objective; 0.8 mm for a 10x, NA =
0.55 objective; and 1.6 mm for a 5x, NA = 0.12 objective). The fluorescence emission
from the sample was collected with the same objective from a PMMA fluidic chip and
directed through the dichroic filter, then a band pass filter (719AF40, Omega Optical),
and finally a long pass filter (690ALP, Omega Optical) to spectrally isolate the emission
from scattered radiation. The isolated emission was then directed onto a reflecting
surface of a mirror, which was placed at a 450 angle of incidence with respect to the
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optical path to direct the fluorescence onto the CCD camera. A plano-convex lens
(AC254-100, focal length = 100 mm) was placed between the mirror and EMCCD
camera, which generated a fluorescence image onto the CCD.
a

Figure 2.1 (a) Optical set-up of the imaging system using epi-illumination and
employing a large FoV. The beam from the diode laser (λ = 660 nm) was isolated using
a laser line filter (F1) and then shaped with a plano-convex lens (L1), which was used to
focus the laser beam behind the input aperture of the microscope objective (OBJ).
Following beam shaping, it was directed by a dichroic filter (DF) into the OBJ with the
collimated laser beam impinging upon a multi-channel microchip. The fluorescence
signal generated from the chip was collected by this same objective, passed through the
DF and spectrally selected using a long pass filter (F2) and an interference band pass
filter (F3). A mirror (M) was used to steer the fluorescence signal onto a CCD after
passing it through a lens (L2), which focused the radiation onto the photoactive area of
the CCD. The total magnification of the system was 40x. (b) An optical micrograph
showing a section of the multi-channel microfluidic chip; the fluidic network consisted of
microchannels with dimensions of 30 µm wide x 20 µm deep and a pitch of 25 µm. All
channels had a common sample input reservoir. The driving electric field was applied at
this reservoir and another on the opposite end of the fluidic network (not shown) to drive
the sample electrokinetically through the imaging area. (c) Diagram showing the
operation of the CCD in a frame transfer mode with image accumulation occurring
during single molecule travel within the FoV of the microscope. The images of single
molecules produced streaks on the CCD due to the molecular transit time being greater
than the CCD exposure time and multiple frames summed to produce the final image.
Continued on next page
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Figure 2.1 (B and C). See caption above.
The EMCCD camera (Cascade 1K, Photometrics, Tuscon, AZ, USA) was a
frame transfer CCD equipped with signal enhancement via on-chip gain and possessed
8 µm x 8 µm pixels configured in a 1004 x 1002 front illumination format. The camera
had a 10 MHz digital converter and a 16-bit digitization range. The frame transfer
capability of the EMCCD allowed near 100% duty cycle when single molecules were
tracked along their flow path within the illumination field. The CCD camera was
thermoelectrically cooled to -300C to minimize dark noise and operated at the optimal
gain to maximize the SNR in the measurement.
2.2.2 Multi-channel Illumination
The optical system was configured in an epi-illumination format (see Figure 2.1a)
with beam shaping optics that generated a collimated output of the excitation source
through the microscope objective for wide-field illumination. The collimated beam was
used to irradiate a series of parallel microchannels. The system was operated with a
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laser power of ~25 mW generating an irradiance of 1.9 x 1020 photons cm-2 s-1 for the
40x objective. For a dye such as AlexaFluor 660 that possesses an absorption cross
section of 1.82 x 10-16 cm2 (molar absorptivity = 110,000 cm-1M-1) and a fluorescence
lifetime of ~1 ns, optical saturation occurs at an irradiance of ~5.4 x 1024. Therefore, the
system is currently being operated well below optical saturation.
2.2.3 Microfluidic Design
A PMMA microchip was designed for high throughput single molecule data
processing that consisted of a series of flow channels tightly packed to provide the
ability to image a number of single molecule experiments within the microscope’s FoV.
The microfluidic devices were fabricated via direct milling of the fluidic vias into a PMMA
wafer

using

a

Kern

MMP2522

micromilling

machine

(KERN

micro-und

Feinwerktechnick, GmbH & CO, Murnau Westried, Germany). The device consisted of a
series of microchannels with dimensions of 30 µm in width, 20 µm in depth and a pitch
of 25 µm. All channels possessed a common sample reservoir (Figure 2.1b). Following
micromilling, the device was sonicated for 1 min in IPA and rinsed thoroughly with
deionized water. A PMMA cover plate (125 µm thickness) was placed on the device to
enclose the microfluidic channels. The chip assembly was clamped between two glass
plates and annealed in a GC oven at 107oC (slightly above the Tg of PMMA) for 22 min.
2.2.4 Chemicals and Reagents
Stock solutions of Tris-Taps-EDTA (TTE) buffer (10x) were diluted to obtain 1x
TTE solutions (pH = 8.7) using nanopure water obtained from a Barnstead NANOpure
System (Model D8991, Dubuque, IA). Fluorescence reagents used included AlexaFluor
660 and Syto-63 (Molecular Probes, Eugene, Oregon, USA). λ-DNA (48.5 kbp) was
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obtained from Molecular Probes and diluted in 1x TTE buffer to the required
concentration after being labeled with Syto-63 at a molar ratio of 5:1 (bp:dye). Single
stranded DNA (ssDNA, 60 bases in length) were 5’ labeled with AlexaFluor 660
(Molecular Probes) and a stock solution (80 nM) was prepared using a 1x TTE buffer.
Double-stranded DNA (dsDNA, 15 bp in length) was obtained from Molecular Probes as
well; the duplex had the sense strand labeled with AlexaFluor 660 at its 5’ end while the
complementary strand (anti-sense strand) was labeled with BHQ-3 at is 3’ end. Stock
solutions (0.4 μM) of the duplex were prepared in Tris/HCl buffer containing 20 mM TrisHCl, 10 mM MgCl2 and 10 mM KCl at pH 7.5. Dilutions from this stock solution to the
desired concentrations required for the single molecule experiments was accomplished
with the same buffer. In all cases, buffer solutions were filtered through 0.2 µm filters
prior to sample preparation.
Stock solutions of λ-DNA molecules were labeled with an intercalating dye (Syto63) and diluted in 1x TTE buffer to 10 pM. This concentration was selected to keep the
single molecule occupancy probability low to reduce the double occupancy probability.
With the system possessing a probe volume of 0.8 fL (CCD pixel size = 8 μm x 8 µm), a
sample concentration of 100 pM produced a single molecule occupancy probability of
0.01 (probability of double occupancy = 0.0001).
2.2.5 Single Molecule Tracking via Frame Transfer EMCCD Operation
The system was optimized for its single molecule sensitivity when operated in the
frame transfer mode using λ-DNA (48.5 kpb) labeled with Syto-63 and diluted in 1x TTE
buffer. Single λ-DNA molecules were loaded into the common sample reservoir of the
PMMA wafer and driven through the microfluidic channels by electrokinetic pumping
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using a high voltage power source (Spellman CZE1000R, Hauppauge, NY, USA). The
movement of the molecules through the illumination zone generated streak images for
each single DNA molecule when the system was operated in the frame transfer mode
and multiple images could be combined. A schematic representation of this process
(frame transfer with image accumulation) is shown in Figure 2.1c. A streak image
resulted from the collection of fluorescence signal from the same molecule into potential
wells along a single column of the EMCCD as the molecule migrated through the FoV.
The single fluorophore detection capability of the system was evaluated using
DNA molecules that were end-labeled with a single AlexaFluor 660 dye molecule. In
this case, only a single image frame was used for the presented data due to the short
bleaching lifetimes associated with single chromophore assemblies.
2.2.6 Bulk Fluorescence Measurements
Emission spectra of the duplexed DNA/AlexaFluor 660 constructs used for the
bulk melt analyses were acquired using a FLUOROLOG-3 spectrofluorometer (Horiba
Jobin Yvon, Edison, NJ). The spectrometer was equipped with a 450 W xenon lamp and
a cooled Hamamatsu R928 extended-red photomultiplier that was operated at 900 V in
the photon-counting mode. The cuvette was thermostatically controlled in order to
provide the required temperatures for the melt analysis.
2.3 Results and Discussion
2.3.1 Multichannel Illumination and System Optimization
The optical system was operated using epi-illumination (see Figure 2.1a) with
beam shaping of the laser source to generate a collimated light output from the
microscope objective for wide-field illumination to provide the simultaneous excitation of
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fluorophores traversing through a series of channels contained within the objective’s
FoV. The channel dimensions of the fluidic network were 30 µm (width) x 20 µm
(depth), with the depth selected to provide sufficient single molecule sampling efficiency
(SE), which was determined by the depth of focus of the microscope objective used for
collecting the fluorescence (1.4 µm for 40x objective; 6.6 µm for 10x objective; and 60.1
µm for the 5x objective), and the percentage of molecules traveling through the
illumination zone, which in this case is near 100%. The 40x objective (NA = 0.75) was
used for single fluorophore measurements due to its high collection efficiency in spite of
its smaller depth of focus. Therefore, the SE for our system for single fluorophores was
approximately 7% (100% x 1.4/20). However, we are not using a pinhole aperture in the
secondary image plane of the relay objective, which will allow for a larger depth of focus
for the optical system than that calculated above and as such, the SE determined above
should be considered a minimum estimation only.
The 40x objective generated a FoV of 200 µm, which allowed imaging 5
microchannels with the current fluidic architecture. Changing the imaging objective to a
lower magnification would allow for the processing of more fluidic channels (see Table
2.1). For example, the use of a 5x objective would provide the ability to image 30
channels with the channel architecture used herein due to its larger FoV. However, the
cost for this higher throughput is reductions in the collection efficiency of the resulting
fluorescence emission, which could potentially reduce single molecule sensitivity.
Clearly, reductions in the channel width and pitch could significantly improve the
number of channels we could image. For example, using a microfluidic chip with a 1 µm
wide channel and a pitch of 1 µm, which can be fabricated using optical lithography,
would permit the ability to image 100 such channels for a FoV of 200 µm.
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Table 2.1 System throughput and SMD signal-to-noise ratios for different FoVs.
Total Magnification
(Magnification/Numerical
Aperture)

Effective Field
of View (FoV)

Number of
Single
Theoretical
channels within Molecule SNR
Single
the FoV (30 µm
for λ-DNA
Molecule
x 20 µm; 25 µm
stained with Throughput
pitch)
Syto-63

40x/0.75

200 µm

5

810

6.7 x 104

10x/0.5

800 µm

17

510

2.28 x 105

5x/0.25

1.6 mm

30

314

4.02 x 105

2.3.2 Detection of Single λ-DNA Molecules
Experiments were first carried out at different electric field strengths to establish the
transport velocity that would yield optimal signal-to-noise ratio (SNR) for the single
molecules, which in this case were λ-DNA molecules stained with Syto-63, since the
molecular transit time should be approximately equal to the photobleaching time to
provide the highest SNR.38 Results from 10 different measurements were averaged and
plotted versus the applied field strength, which generated an optimal field strength of
~80 V/cm (see Figure 2.2a). At this field strength, the linear velocity was 0.01 cm/s,
which was based on the applied field strength and the electrophoretic mobility of λ-DNA
loaded with Syto-63. At this linear velocity and FoV, the molecular transit time was
estimated to be ~1.6 s. We note that the processing rate is directly related to the flow
velocity for flow-based measurements and as such, higher field strengths would result in
higher system throughput. Even at field strengths of 300 V/cm (0.037 cm/s), we were
able to generate sufficient SNR to detect single λ-DNA molecules.
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Figure 2.2 (a) Plot of the signal-to-noise ratio (SNR) at different field strengths used to
transport single molecules through the irradiation zone of the imaging system. The SNR
values were obtained from an average of 10 different measurements. (b) Fluorescence
image from the CCD for a single molecule tracked along several pixels of the CCD,
which was accumulated from two image frames that were acquired using 100 ms
exposure time per frame with the fluorescence collected using a 40x objective (NA =
0.75).
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To demonstrate the ability to track single dsDNA molecules traveling
electrokinetically through the irradiation zone, experiments were carried out using single
and multiple microchannels. Figure 2.2b shows a fluorescence image of a single DNA
molecule tracked along the FoV of the imaging system by accumulating two image
frames acquired using a 100 ms exposure time per frame. From the length of the streak
(~60 µm) and the image accumulation time (2 frames at 100 ms per frame), we
estimated the linear velocity to be 0.03 cm/s, very close to that determined above at a
field strength of 300 V/cm.
To evaluate the sample throughput (ST) capabilities of the system, a 100 pM solution of
λ-DNA was electrokinetically driven through the system at a field strength of 300 V/cm
and the fluorescence image was collected using the 10x objective (NA = 0.5); the FoV
of the system was 800 μm, which allowed imaging 17 channels. With the system
operated in a frame transfer mode, the SMD sensitivity was improved by using 3x
binning (3 x 3) with the multiplication gain of the EMCCD set at 3,700. Figure 3a shows
one image frame from a series of images acquired for single λ-DNA molecules stained
with Syto-63 traveling through the illumination zone. Each fluorescent streak represents
an individual DNA molecule migrating through the chip due to the low probability of
double occupancy per imaging pixel at this DNA concentration. The intensity distribution
of this image was constructed by transforming the image in Figure 3a to a 3-D image
(see Figure 2.3b).
To further demonstrate the ability to increase the throughput of the multi-channel
fluidic device, a 5x objective (NA = 0.25) was incorporated into the imaging system and
the same sample concentration of λ-DNA as that use above (100 pM) was analyzed.
Figure 2.3c presents a single image frame showing photon bursts from single λ-DNA
77

a

Direction of Transport
Microchannels
b

Relative Intensity
Pixel Number (microchannels)

Figure 2.3 (a) Image of single λ-DNA molecules migrating through a series of
microchannels (17-channels are shown). The image was acquired using a 10x (NA =
0.5) objective at an exposure time of 100 ms with the CCD multiplication gain set at
3,700 (controller gain set at 1). The sample solution (100 pM) was electrokinetically
pumped through the fluidic channels with a field strength of 300 V/cm (linear velocity =
0.037 cm/s). Each fluorescent spot represents a single λ-DNA molecule. (b) 3-D image
showing the intensity distribution of λ-DNA molecules shown in (a). (c) Single λ-DNA
molecules migrating through series of 25 microchannels. Image was acquired using a
5x objective (NA=0.25). In all cases, the λ-DNA was stained with Syto-63 at a dye to
base pair ratio of 5 to 1. Continued on next page
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Figure 2.3 (C) see caption above.
molecules in 25 different microchannels. This objective generated a FoV of 1.6 mm,
which allowed imaging 30 channels using our present fluidic architecture, but only 25
are shown in Figure 3c. Therefore, the single molecule processing throughput was
increased by a factor of 6 compared to the 40X objective due to the higher FoV afforded
by the lower power objective.
For flow-based single molecule detection experiments in which the single
molecule events are dynamically transported through a fixed interrogation (sampling)
zone, the sample throughput (ST) can be calculated from;33
ST = SE × DE × DR × DC

(2.3)

where SE represents the percentage of molecules that are sampled during the
experimental run (1.0 for the 5x objective), DR is the delivery rate of molecules into the
sampling volume, DC is the readout duty cycle (1.0) and DE is the detection efficiency.
The DR can be calculated using;
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DR = Fv × Cb

(2.4)

where Fv represents the volume flow rate (cm3 s-1) and Cb is the molecular
concentration (molecules cm-3). DE is basically the percentage of molecules detected
above a threshold value, which is selected to minimize the number of false positive
events registered during the experiment.

For the present experiments, using a field

strength of 300 V/cm and 100 pM concentration, the DR was determined to be 1.34 x
104 molecules s-1. For DE = 1 and SE = 1.0, a ST of λ-DNA was estimated to be 13,400
molecules/s in each microchannel with a total system throughput of 4.02 x 105
molecules/s in the 30 channel network.
As noted above, scaling down the microchannel width and pitch can be used to
further increase the ST of the present system. For example, reducing the channel width
to 3 μm with a pitch of 3 μm and using the 10X objective to produce a reasonable
collection efficiency (NA = 0.5), will increase the number of channels that can be imaged
to 133 with a corresponding ST of 1.78 x 106. A further reduction in channel width to 1
µm with an inter-channel spacing of ~400 nm (diffraction limited resolution is ~λ/2) will
allow the system to image 571 microchannels using the 10x objective increasing ST to
7.65 x 106 molecules/s. While this represents a significant increase in ST over our
previous work

33

, it also indicates exceptional increase in ST over previous research

reports.34, 39-46 For example, Van Orden et al. reported a ST of 2000 DNA fragments s-1
using a CCD operated in a snap-shot mode ,34 while Ma et al. reported an ST of ~ 8500
molecules s-1 from their single molecule spectroscopy studies.43 Recently, Chansin et
al. speculated a throughput of ~1500 molecules s-1 using their synthetic nanopores to
measure DNA translocation events.46
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2.3.3 Detection of Single DNA/Fluorophore Conjugates
For these experiments, we utilized the 40x (NA = 0.75) objective and the optimized field
strength (80 V/cm) for producing a high single molecule SNR to enhance sensitivity for
the detection of single fluorophore molecules that were conjugated to ssDNAs.
Solutions of ssDNAs labeled with AlexaFluor 660 were prepared in 1x TTE buffer and
diluted to 750 pM in the same buffer. The samples were electrokinetically pumped
through the microfluidic network and an exposure time of 100 ms was selected for the
CCD per image frame when operated in FTM. With the 40x microscope objective, the
laser excitation volume was calculated to be 0.12 nL, which in this case is not the
sample probe volume due to the fact that the irradiation area was sub-divided into
smaller elements defined by the pixels comprising the EMCCD camera. The probe
volume was actually calculated from the size of each individual pixel of the EMCCD (8
µm x 8 µm) and the total magnification of the optical system (40x), producing a probe
volume of 0.8 fL. Based on this probe volume size and the concentration used for these
experiments (750 pM), the single molecule occupancy was 0.3 and the double
occupancy probability was 0.09. Figure 2.4a shows a fluorescence image of individual
ssDNA molecules end-labeled with AlexaFluor 660 migrating through the fluidic device.
From this image, single molecule streaks were not observed as was seen in Figure
2.2b. This was a result of the binning operation performed on the image (3 x 3 bin), the
relatively small linear velocity used and the data image shown in Figure 2.4a taken from
a single frame. To enhance spot visualization of the single molecules, we acquired 10
images of the blank (1x TTE buffer) from which the standard deviation was calculated,
which was found to be 42 units for an average background of 2,019 CCD units per pixel;
a threshold value was selected as 3-times the standard deviation above the average
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background (2,145), which was subtracted from a sample sub-frame (25 x 42 pixels) as
indicated in Figure 2.4a. This also reduced false positive signals resulting from
statistical variations in the background.

Application of this threshold condition

generated the sub-frame image shown in Figure 2.4a. This sub-frame represents
approximately a 5 µm (wide) x 8.4 µm (length) area within a single microchannel. From
this image, fluorescence from single molecules were clearly visible, which could be
individually counted to extract quantitative information.

This same operation was

applied to an image acquired when there was only buffer in the microfluidic network with
this image shown in Figure 2.4b.

As can be seen from this image, there was no

fluorescence registered as that observed in Figure 2.4a.
a

Direction of Transport

Sub-frame

Microchannels

Figure 2.4 (a) Detection of individual dye molecules (AlexaFluor 660) end-labeled to a
60 base ssDNA distributed in different microfluidic channels (5 channels are shown) for
a sample concentration of 750 pM. The dye/ssDNA conjugate was pumped through the
fluidic channels using a field strength of 80 V/cm (linear velocity = 0.01 cm/s). To further
visualize the fluorescent photon bursts in this image, a sub-frame (25 x 42 pixels) was
expanded and quantitative information extracted by applying a threshold condition to
this sub-frame (see text for details). (b) Image acquired when the fluidic channels were
filled with buffer only, and the processed sub-frame with application of the threshold
condition as described in the text. Continued on next page
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Figure 2.4(b) see caption above.
From careful inspection of the sub-frame image shown in Figure 2.4a, we were
able to count 64 photon bursts generated from single ssDNA-AlexaFluor 660
conjugates.

From the size of the image taken (5 x 8.4 x 1.4 µm3, Pv) and the

concentration of the conjugates used herein (750 pM, Cb), we could calculate the
number of expected events (Nev) from;
Nev = Cb Pv

(2.5)

Insertion of the appropriate numbers into eq. 2.5 yielded a value of 26, which is
somewhat smaller than the 64 events observed in the image sub-frame shown in Figure
2.4a. This can be reconciled considering that the probing volume was determined by the
depth of focus of the microscope objective used here. Because there is no pinhole
(confocal geometry) located in the secondary image plane of the objective, we are
processing molecules outside of the 1.4 µm depth of focus of this 40x objective, making
the observed event number higher than that calculated using eq. 2.5.
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Different concentrations of ssDNA-AlexaFlour 660 conjugates were next
evaluated using our multi-channel single molecule detector system and processed with
the same threshold value as noted above.

An average of eight images per dye

concentration was plotted with the calibration plot constructed from the number of
photon burst events versus the conjugate concentration. This analysis was performed
on a sub-frame image with a size of 25 x 42 CCD pixels. The number of spots (single
molecule events) observed was linear with the sample concentration yielding a
correlation factor of 0.98 (data not shown).
2.3.4 Fluorescence Quenching Assay
We were next interested in evaluating the capability of our imaging system to
monitor biochemical reactions using fluorescent probes to signal the extent of the
reaction. We employed a model test case using an oligonucleotide duplex (15 bp) with
one strand (sense strand) labeled with AlexaFluor 660 at its 5’ end and the
complementary strand (anti-sense strand) labeled with the Black Hole Quencher-3
(BHQ-3) at its 3’ end to create sufficient proximity for resonance energy transfer
quenching of the fluorescence from AlexaFluor 660 for the duplexed form of this
construct (see Figure 2.5a). Melting of the duplex could be affected by introducing
thermal energy into the system, producing ssDNAs that would result in the generation of
fluorescence from the sense strand. Therefore, a melt analysis for this oligonucleotide
could be generated by plotting the number of single molecule events observed from the
sense strand versus the temperature.
For these experiments, the duplexed samples (750 pM) were prepared in
Tris/HCl buffer containing 20 mM Tris-HCl, 10 mM MgCl2 and 10 mM KCl at pH 7.5.
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The microfluidic device was equipped with a strip heater, which was placed 200 µm
upstream from the imaging area. The duplexes were electrokinetically driven through
the fluidic device at the desired temperature using an 80 V/cm field strength. When
operated at room temperature, there was no fluorescence signal registered on the
detector. The absence of fluorescence photon bursts in the EMCCD image clearly
indicated that the reporter dye was sufficiently quenched by BHQ-3 and no single
stranded constructs could be seen (data not shown). This is in agreement with previous
studies using this fluorophore-quencher pair with a reported 96% quenching efficiency.47
a
3'-CGCTTTTTAAAAAGC-5'-AF 660
5'-GCGAAAAATTTTTCG-3'-BHQ-3

Heat (67oC)
No Heat

3'-CGCTTTTTAAAAAGC-5'-AF 660

3'-CGCTTTTTAAAAAGC-5'-AF 660
5'-GCGAAAAATTTTTCG-3'-BHQ-3

Fluorescence

No Fluorescence
5'-GCGAAAAATTTTTCG-3'-BHQ-3

Figure 2.5 (a) Fluorescence single molecule quenching assay for determining duplex
Tm using a 15-base pair oligonucleotide labeled with AlexaFluor 660 on its 5’ end and its
complement labeled with the Black Hole Quencher-3 (BHQ-3) on its 3’ end. (b)
Fluorescence single molecule image of the 15-bp oligonucleotide when the sample was
heated to 67oC. Fluorescence from single DNA/AlexaFluor 660 molecules were visible
as shown in this image due to duplex melting, producing ssDNAs. Also shown is the
sub-frame of this image (37 x 67 pixels) that was processed as described in Figure 4.
(c) Plot of number of single molecule events counted over a fixed interval of time at
different sample temperatures (rectangles, concentration = 750 pM). Also shown is a
plot of the normalized fluorescence intensity of the duplexed DNA at different
temperatures using a bulk measurement (dsDNA concentration = 40 nM, circles; and 1
nM, triangles) measured using a conventional fluorometer (λex = 675 nm). Continued on
next page
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Figure 2.5 (b and c) See caption above.
To generate ssDNA in the flowing sample, the strip heater was then turned on
with the temperature set to 67oC. Figure 2.5b shows a single molecule fluorescence
image of photon bursts generated from the ssDNA constructs when imaged at this
86

temperature. To clearly visualize these spots and extract quantitative information by
counting the single molecule events, the threshold condition was applied as discussed
earlier. A sub-frame (37 x 67 pixels) was selected and processed (see Figure 2.5b). The
presence of fluorescent photon bursts in the 67oC image versus that taken at room
temperature is expected; the thermal energy introduced into the system produced a
sufficient population of ssDNAs due to thermal denaturation of the duplexed DNA and
thus, the energy transfer interaction between the two labels is eliminated because of
proximity considerations.
A melt analysis was then conducted on the oligonucleotide duplex by taking
images of single molecules traversing through the interrogation zone at different
temperatures and counting the number of events (i.e., ssDNAs) at each temperature
investigated. This analysis generated a sigmoidally-shaped plot (see Figure 2.5c) with a
sharp rise in the number of single molecule events between 30oC and 50oC with a
midpoint at ~40oC. This midpoint represents the melting temperature (Tm) of the duplex,
which is defined as the temperature in which 50% of the DNA is in its double-stranded
form and 50% in its single-stranded form. This value agrees favorably with that obtained
from a theoretical prediction (Tm = 41.7oC) using oligonucleotide analysis software.48, 49
The melting temperature of the duplex was also estimated by measuring fluorescence
from a bulk sample of the duplex (1 nM) as a function of temperature using a standard
fluorometer (λex = 675 nm). Figure 2.5c shows the resulting plot of fluorescence intensity
obtained at various temperatures, which generated a Tm value of 43oC. The slight
deviation of this value (43oC) compared to the single molecule result could be attributed
to the slightly higher concentration of the duplex used in the bulk solution since the
inter-strand duplex Tm depends on concentration.48
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This supposition was further

supported by the experimental Tm (50oC) obtained for a 40 nM solution of this same
duplex (see Figure 2.5c).
As an example of the necessity for high throughput processing required to
perform this measurement, we were able to reduced the processing time by a factor
directly related to the number of channels imaged during the single molecule
measurement, which in this case yielded a 5-fold reduction in processing time
compared to a single point SMD flow-based scenario. Implementation of a smaller
microchannel width and pitch producing a higher packing density of channels would
significantly increase the data processing rate. For 1 µm wide channels and a pitch of
400 nm, the number of channels that could be effectively imaged using a 200 µm FoV
would be 143 channels, reducing the processing time by 143-fold.
2.4 Conclusion
We have demonstrated the ability to detect single molecules using a frame
transfer EMCCD in a high throughput format using a series of microchannels packed
into the FoV of our imaging system. The system was configured in an epi-illumination
format with beam shaping optics to generate a collimated output adequate for wide field
illumination and providing adequate irradiance and SNR to observe photon bursts from
single fluorophore molecules. The present design allowed imaging 30 microchannels
when λ-DNAs were stained with an intercalating dye. This represents a 12-fold increase
in the sample throughput (4.02 x 105 molecules/s) over our previous work, which
employed a CCD operated in a time-delayed integration mode.33 The reported optical
system also provided, for the first time, single fluorophore sensitivity for a multi-channel
flow-based single molecule experiment as demonstrated by the photon burst detection
of ssDNAs end-labeled with AlexaFluor 660. However, in this case, a 40X objective with
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its high NA was required to collect sufficient numbers of fluorescent photons to produce
adequate SNR for detection of these single fluorophore molecules. This resulted in a
decrease in the system sample processing throughput due to the reduced FoV (200 µm
vs. 1,600 µm for a 5X objective), which permitted the simultaneous interrogation of 5
channels (40x objective) versus 30 channels (5x objective). However, reducing the
microchannel width and pitch can significantly improve the sampling throughput for the
40x objective using optical lithography to produce a molding tool for micro-replicating
high density fluidic networks in polymers, such as PMMA.
The results obtained from a fluorescence quenching assay associated with DNA
duplex melting demonstrated the ability of our system to generate high throughput data
processing appropriate for evaluating the fate of a biochemical reaction by monitoring
population differences between reactants and/or products in a single molecule
approach. The appealing aspect of the single molecule approach is the ability to use low
concentrations of precious biological reactants and enzymes, the exquisite sensitivity
associated with single molecule detection to record subtle changes in the reaction
profile and the ability to monitor reactions efficiently in ultra-small volumes. This will be
particularly attractive for high throughput screening applications, where the effects of
elements from a large combinatorial library must be screened against a therapeutic
target (i.e., bioenzyme). Due to the large size of most combinatorial libraries (>106
elements), high throughput processing is critical.
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CHAPTER 3
CYCLIC OLEFIN COPOLYMER PLANAR WAVEGUIDE EMBEDDED IN A MULTICHANNEL POLY (METHYL METHACRYLATE) FLUIDIC CHIP FOR EVANESCENCE
EXCITATION
3.1 Introduction
Lab-on-a-chip (LOC) systems offer a number of compelling advantages compared to
conventional bench-top systems, including the ability to process large amounts of
chemical/biochemical information due to the ability to build chips in a highly parallel
fashion.1-6 A major challenge associated with these miniaturized systems is the
associated reduced sample and reagent volume requirements, which place a high
demand on the detection system to provide the required sensitivity for interrogating a
few molecules present in the resulting detection volume. Whilst several detection
methods exist for microfluidic systems,7,8 laser-induced fluorescence (LIF) has been
widely adopted due to the high sensitivity, selectivity and extremely low limits-ofdetection obtainable.9,10
Classical optical configurations for LIF are often based on epi-illumination or transillumination formats,11,12 in which both excitation and fluorescence light propagate in the
same optical path with spectral sorting accomplished using dichroic filters. Another
optical configuration, which has found applications in LIF detection, is total internal
reflection (TIR) fluorescence,13-15 in which fluorescent samples are excited using a
surface-confined excitation field. Several reports have documented the use of TIR
optics which use prisms,16-18 microscope objectives,19,20 and optical fibers.21,22 In all
cases, fluorescence excitation utilized the evanescent field generated by TIR at a high
refractive index to a low refractive index boundary.
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The penetration depth of the evanescent field is usually fairly small (<750 nm) with
the absolute value dependent upon the excitation wavelength, the refractive indices of
the waveguiding material and substrate and the launch angle of the incident light. The
intensity of the evanescent field, which is proportional to the square of the electric field
amplitude,23 normally drops off exponentially into the lower index medium, thus enabling
the realization of small excitation volumes.
A

common

class

of

materials

used

for

TIR

fluorescence

is

optical

waveguides,24,25 which offer a number of advantages, such as the realization of
compact sensing elements suitable for LOC applications and the potential for fabricating
multiple sensors on a single chip.26 Planar waveguides for biosensing applications have
been made using a variety of materials such as metal films,27 metal oxide films,28
photonic crystals,29,30 and silicon oxynitride.31 While glass remains the most commonly
used material for waveguide applications,15,32 its incorporation into other sample
processing units required for LOC sensing is a challenge due to its limited and
sometimes costly fabrication modalities. As a result, polymer-based waveguides33,34
have attracted much interest in many LOC applications because of their simple
fabrication characteristics and in some cases, their favorable optical properties.35 Also,
the ease of integrating these materials into instruments suitable for point of care (POC)
applications is of great value.
Several polymer materials have been employed for waveguiding, including
poly(dimethylsiloxane), PDMS,36,37 SU-8,26,38-40 and poly(methyl methacrylate), PMMA.41
As an example, Xu et al.41 recently demonstrated the use of a PMMA-based airembedded planar waveguide for reading DNA microarrays. This waveguide was
fabricated in a single step using double-sided hot embossing from metal mold masters.
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Another polymeric material, which holds great promise as a waveguide material, is
cyclic olefin copolymer (COC). This class of polymers has properties that can be
tailored within a wide range of characteristics during polymerization.42 COC is a
copolymer of ethylene and norbornene produced via a metallocene catalyst-mediated
polymerization with glass transition temperatures (Tg) that range from 75oC to 180oC
and depends on the amount of norbornene in the copolymer. COC possesses high
optical

transparency,

excellent

electric

properties,

high

rigidity,

excellent

biocompatibility, very good resistance to acids and alkalis and good thermal
properties.42,43 Several works have reported on the microfabrication of COC
substrates,44-49 which have created avenues for expanding the utility of this polymer
especially as a waveguide material due to its exquisite optical properties.50
Although much progress has been made toward integrating waveguides to
microfluidic systems,14,51-53 effective propagation of light through a single planar
waveguide for evanescent excitation in multiple fluidic channels suitable for high
throughput biochemical analysis has not been reported. In this Chapter, we present for
the first time the fabrication of a COC waveguide that was embedded in a PMMA
substrate serving as a cover plate for a PMMA substrate that contained a series of
fluidic vias. The COC waveguide was situated orthogonal to the microfluidic channels to
provide parallel evanescent excitation of the material moving through the fluidic vias.
The fluidic channels were hot embossed from a metal master on a 250 µm thick PMMA
sheet, which was thermally fusion bonded to the PMMA cover plate containing the
embedded COC waveguide. To carefully control the laser launch angle into the
waveguide to near the critical angle, which is defined by the refractive index of COC (n
= 1.53) and PMMA (n = 1.48), a monolithic prism was integrated to the COC waveguide
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in a single fabrication step, eliminating the need for an external prism and index
matching oil. In another design, laser light was coupled to the embedded waveguide
through an optical fiber (N.A. = 0.12), which minimized light loss due to scattering.
3.2 Experimental
3.2.1 Materials and Reagents
COC sheets (grade: 5010L; Tg = 110oC; n = 1.53) were obtained from Topas
(Topas Advanced Polymer, USA); the molecular structure of Topas COC is shown in
Figure 3.1a with the monomer units represented as x and y. Toluene was obtained from
Fisher Scientific (Fisher Chemicals, USA) and used as supplied to make a polymer
solution of COC.

The COC solution was obtained by dissolving pieces of COC in

toluene, which made a clear solution of the polymer in 24 h. A PDMS base and curing
agents were obtained from Dow Corning (Dow Corning Corporation, Midland, USA.).
Optical fibers (NA = 0.12) were obtained from Thorlabs (Thorlabs, Newton, NJ, USA)
with the blunt bare fiber end created using a fiber optic cutting tool (Precision Tool kit,
698-STK-100). AlexaFluor 647 was obtained from Molecular Probes (Eugene, Oregon,
USA) with the stock and sample solutions made in 1X Tris-Taps-EDTA (TTE) buffer
(pH = 8.7).
3.2.2 Image Acquisition
All fluorescence images were acquired using a Roper Scientific (Trenton, NJ)
Spec-10 charge-coupled device (CCD) camera that was thermally cooled to -90oC and
contain a 1 MHz digital converter. The CCD had 20 µm pixel sizes that were configured
in a 1340 x 100 back-illuminated format. Scanning electron micrograph (SEMs) images
were acquired using a Cambridge S-260 SEM (Cambridge instruments Ltd. Cambridge,
UK) interfaced with Video Wave 5 program (Real Networks Inc. Washington, USA).
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Atomic force microscopy (AFM) images were acquired using a Nanoscope III instrument
(Digital Instruments, CA).

Figure 3.1 (a) Molecular structure of Topas COC, x and y represent the monomer units,
which are polymerized by metallocene catalyzed polymerization; the Tg can be modified
by increasing or decreasing the amount of norbornene (y) in the monomer mixture
during polymerization. (b) Schematic representation of the fluidic device with embedded
COC core waveguide fabricated with a monolithic prism. (c) Schematic of a dissected
portion of the device showing the multi-channel fluidic architecture and waveguide
geometry. (d) Diagram showing the launching of laser light into the waveguide using an
optical fiber.
3.2.3 Layout of the Integrated System
Figure 3.1b shows a schematic diagram of the multi-channel fluidic device with
an embedded COC core waveguide and monolithic prism. The device consisted of two
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layers; a PMMA cover plate (refractive index, n, = 1.48, Tg = 107oC) into which the COC
core waveguide (refractive index, n = 1.53) was embedded and a PMMA substrate,
which contained the fluidic channels that were replicated/embossed from a metal mold
master (see Figure 3.1c). The waveguide was situated orthogonal to the longitudinal
axis of the fluidic channels along the width of the PMMA cover plate, the size of which
defined the excitation volume in each fluidic channel along with the penetration depth of
the evanescent field. The monolithic prism (see Figure 3.1b) facilitated coupling of light
into the waveguide without the need for an external prism or index matching oil. Figure
3.1d is a schematic of the optical fiber coupled COC core waveguide. The use of the
optical fiber in this design eliminated the need for a prism.
3.2.4 Fabrication of the Embedded Waveguide
The stepwise fabrication process for creating the embedded COC core
orthogonal planar waveguide and monolithic prism is shown in Figure 3.2a. The first
step involved the generation of a PDMS stencil, which was used to form the waveguide
and coupling prism and was produced using a relief made from PMMA. The PMMA
relief consisted of a prism-shaped structure that was aligned to a 1 mm diameter pole
structure (height of structure = 2.0 mm) used to create an access reservoir. The PMMA
relief was replicated from a brass mold master fabricated by high precision micromilling
(using Kern MMP micromilling and drilling machine).54,55 A PDMS pre-polymer solution
was obtained by mixing the PDMS base and the curing agent at a ratio of 10:1 by mass.
This solution was degassed and loaded through the injection port of a molding frame
containing the PMMA relief to completely fill the mold cavity. Curing of the PDMS prepolymer solution was achieved in 1.5 h using a vacuum oven set at 70oC. The resulting
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PDMS stencil containing the prism-shaped recess and a 1 mm diameter reservoir
(created by the 1 mm diameter pole) was peeled from the PMMA relief.
The PDMS stencil was then placed onto a sheet of PMMA containing a prefabricated waveguide channel (200 µm x 200 µm). The waveguide channel was
replicated onto the sheet PMMA from a brass mold master that was fabricated by high
precision micromilling. The prism-shaped recess on the PDMS stencil and the reservoir
were carefully aligned with both ends of the waveguide channel under a microscope. A
COC solution (melt) was then introduced into the waveguide channel through the
reservoir to fill the channel and the prism-shaped recess. This assembly was placed on
a dry glass plate and allowed to cure in a vacuum oven for 24 h at room temperature.
Following curing of the COC, the PDMS stencil was carefully peeled from the PMMA
sheet, which formed the embedded COC core waveguide and the monolithic coupling
prism. Figure 3.2b shows an image of the embedded COC waveguide with monolithic
prism.
3.2.5 Fabrication of the Optical-Fiber-Coupled (OFC) Waveguide
The OFC waveguide was fabricated following the procedure outlined in Figure
3.2a with slight modifications. In this case, the prism-shaped structure in the mold (see
Figure 3.2a (i)) was replaced with a second pole (1 mm diameter and 2 mm tall), which
allowed the generation of a PDMS stencil with two aligned reservoirs (each situated at
both ends of the PDMS stencil). An optical fiber (OD = 125 µm, core diameter = 62 µm)
was cleaned with acetone and inserted into the waveguide channel with the tip of the
fiber situated 5 mm from the insertion end of the channel. The optical fiber was kept in
place using the fabricated PDMS stencil, which was placed on the PMMA wafer with the
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reservoirs aligned to the ends of the waveguide channel and subsequently clamped to a
glass plate. The COC melt was introduced into the waveguide channel through the
(a)

Figure 3.2 (a) Schematic representation of the stepwise process for the fabrication of
the embedded COC core orthogonal waveguide. In the first step, the mold structures
were fabricated in PMMA wafer via hot embossing from a mold master made using high
precision micromilling (i). The mold was assembled for PDMS casting using a prealigned cover plate containing injection reservoirs (ii) for the introduction of the PDMS
prepolymer (PDMS + Curing agent at 10:1 ratio) (iii).The PDMS stencil was peeled from
the mold after curing at 70oC for 90 min (iv) and placed on the surface of a PMMA sheet
containing a pre-fabricated waveguide channel (waveguide channel was embossed
from a mold master fabricated using high precision micromilling), the injection reservoir
and prism recess for launching light into the waveguide were aligned with respect to the
waveguide channel (v). The COC melt (prepared using toluene as a solvent) was
introduced through the reservoir to fill the entire waveguide channel and the prism
recess (vi). This created the embedded waveguide with the monolithic prism in a single
casting step (vii). The waveguide assembly was further integrated to multiple fluidic
channels (viii) that were prepared using hot embossing into PMMA. The fluidic substrate
and PMMA sheet containing the waveguide, which served as the cover plate for the
fluidic network, were thermally fusion bonded at approximately 105oC, near the Tg of the
polymeric materials. (b) Photographs of the PMMA sheet showing the embedded
waveguide (i) with the integrated monolithic prism (to the right is the SEM of a section of
the prism). (c) Photograph of the OFC waveguide (i) showing the fiber-coupling point (to
the right is an optical micrograph of the coupling site) and the optical fiber (ii). Continued
on the next page
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(c)
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ii

Figure 3.2 (b and c) see caption above
access reservoir to fill the waveguide-defining channel, which spanned a length of 3 cm.
This assembly was placed on a dry glass plate and allowed to cure in a vacuum oven
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for 24 h. At the end of the curing period, the PDMS stencil was carefully peeled from the
PMMA sheet to obtain the optical-fiber-coupled COC core embedded waveguide (see
Figure 3.2c).
3.2.6 Integration of the Embedded Waveguide with the Multi-channel Substrate
The fluidic channels were replicated into a PMMA substrate (thickness = 250 µm)
via hot embossing from a brass mold master, which was fabricated by high precision
micromilling.54,55 This PMMA wafer contained channels with dimensions of 100 µm
width x 30 µm depth and was thermally fusion bonded to the waveguide-bearing PMMA
sheet in an orthogonal configuration with the waveguide spanning the length of the
entire array of fluidic channels. In this case, the PMMA sheet containing the embedded
waveguide served as the cover plate for the fluidic network and also defined the
illumination cross sectional area for each fluidic channel. Figure 3.3a shows an optical
micrograph of the waveguide and the fluidic channel when thermally assembled.
3.2.7 Coupling of Light into the Waveguide
To minimize light lose at the entrance to the waveguide, a collimated laser beam
was passed through a beam expander that was used in the reverse mode to reduce the
beam diameter from 2 mm to ~200 µm. The resulting beam was launched through the
monolithic prism into the waveguide with a launch angle adjusted to 76o (critical angle θc
= 75o) using a goniometer. The critical angle here (θc = sine-11.48/1.53) was defined by
the refractive indices of the PMMA cladding (n = 1.48) and the COC core (n = 1.53).
In the case of the OFC waveguide, the laser light was first coupled into an optical
fiber, which was latter coupled into the OFC waveguide using a fiber-fiber coupler (see
Figure 3.3b).
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a

Waveguide

Fluidic Channels

b

Figure 3.3 (a) Optical micrograph of the embedded waveguide integrated to the fluidic
channels. (b) Schematic representation of laser coupling into the OFC waveguide. The
light was first coupled into an optical fiber (labeled 1), followed by another coupling to
the second optical fiber (labeled 2, which is the fiber coupled to the waveguide) using a
fiber-fiber coupler, which send the input light to the waveguide. (c) The photograph
shows the guiding of light (532 nm) through the length of the waveguide (i) when an
optical fiber was used to couple light into the waveguide; and the scattering of the light
when there was poor coupling between the optical fiber and waveguide (ii). Continued
on the next page
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Fiber to Waveguide
Coupling point

ii
Fiber to Waveguide
Coupling point s

Air-space between
Fiber and Waveguide

Figure 3.3 (c) See caption above
This generated continuous guiding of the light through the waveguide. To demonstrate
the waveguiding capabilities of the OFC waveguide, a 532 nm laser (20 mW) was
coupled into the optical fiber. In Figure 3.3c is shown a photograph of the OFC
waveguide with the 532 nm laser coupled into it (i). The bottom panel of Figure 3.3c (ii)
shows an optical micrograph of the waveguide with the optical fiber not properly coupled
to the waveguide (air space between waveguide and optical fiber). The emerging bright
laser spot in Figure 3.3c (top panel) is a clear indication of continuous light guiding
through the waveguide, whereas the unguided laser (bottom panel) resulted in
significant amounts of scattered light at the optical fiber tip, which indicated improper
coupling to the waveguide.
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3.3 Results and Discussion
3.3.1 Evaluation and Characterization of the Embedded COC Waveguide
To confirm that loading of the waveguide channel with the COC melt generated
an optically homogeneous interface between the COC core and PMMA after curing of
the COC, a scanning electron micrograph (SEM) of the empty waveguide channel and
the COC filled channel were obtained (data not shown). In addition, we also inspected
the COC core for inhomogeneity, for example resulting from air bubbles that may create
speckle patterns in the waveguide due to refractive index changes. Close examination
revealed a highly uniform interface between the COC/PMMA waveguide with no
imperfections at the top of the COC core. These results were further supported by AFM
images (see Figure 3.4) of the surface of the embedded waveguide. As can be seen in
this image, the COC core surface was very smooth showing no evidence of large pits
arising from air bubbles or other materials during its production, which could generate
light propagation losses.
a

b

X = 20.00 µm/div
Y = 4104 nm/div

RMS = 61.248 nm

Figure 3.4 (a) AFM image of the surface of the cured COC planar polymer waveguide
embedded in sheet PMMA; z-scale is 4104 nm/div., x-scale is 20 µm/div. (b) Section
analysis of the waveguide surface, top panel shows the surface roughness with RMS =
61.284 nm.
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Figure 3.5 (a) Optical transmission spectra (600 nm – 900 nm) of COC (black), cured
COC waveguide (red), PMMA (blue), PC (green) and PDMS (purple). (b) Moisture
resistance of COC compared to other polymer waveguide materials.
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Amongst the properties of waveguides that defines their suitability for efficient
light transmission is their optical transmittance at different wavelengths. This is
particularly important for fluorescence applications, because transmission losses not
only introduces propagation losses, but can also give rise to autofluorescence that can
degrade the signal-to-noise ratio in any sensitive fluorescence measurement.35
Therefore, optical transmission spectra were collected between 600 and 900 nm for
both the COC sheet and the cured COC core waveguide material using Ultrospec 4000
UV/VIS Spectrophotometer. A comparison of the optical transmission properties were
made for other potential polymeric waveguiding materials, such as PC, PMMA, and
PDMS. As can be seen in Figure 3.5a, COC showed high optical transparency of ~91%
across the wavelength range scanned, which compared favorably with those of PMMA,
PC and PDMS. In addition, there was no significant difference in the transmission
spectrum obtained for a COC sheet and the cured COC waveguide.
Water absorption is also a critical issue in selecting proper waveguide materials
because water absorption can change the refractive index of the waveguide material
inducing light loss or specularly scattered radiation increasing the background in the
fluorescence measurement. Therefore, an investigation of the moisture resistance of
the embedded COC core waveguide was carried out. A portion of the COC melt was
coated onto a glass slide to a thickness of 200 µm and cured as discussed earlier. Films
of other polymers were also made in a similar fashion but using a solvent in which each
particular polymer showed high solubility. The polymer films were heated to 95oC for 50
min and subsequently weighed. The sample was then immersed into water for 24 h at
room temperature and re-weighed following drying under a constant flow of N2 to
remove surface moisture. The difference in weight was calculated in order to establish
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the percentage of water absorption.50 Figure 3.5b shows the water absorption
characteristics of COC and other polymer films with COC giving the highest moisture
resistance. This result could be related to the more hydrophobic nature of COC,
compared to the other materials.
Another important optical characteristic of waveguides is their transmission
efficiency as a function of waveguide length. We measured light attenuation in decibels
(dB) per unit length (cm) using the equation below;

A = -10log (Pout/Pin) x 1/L

(3.1)

where A is the attenuation in decibels (dB), Pin is the input laser power (in mW), Pout is
the output power (in mW) and L is the length of the waveguide (cm). Light was launched
into the waveguide (launch angle = 76o) near the critical angle (to maximize the
penetration depth) when a plain PMMA sheet (n = 1.48) was thermally fusion bonded to
the COC/PMMA waveguide. Using an input laser power of 4.2 mW, an output power of
1.3 mW was measured resulting in an attenuation of 1.69 dB/cm. From our observation,
the actual light loss was primarily from scattering of the exiting beam from the distal end
of the waveguide before reaching the light sensor.
3.3.2 Waveguide Functionality
As mentioned earlier, propagation of light through a planar waveguide generates
an evanescent electromagnetic field, which penetrates into the surrounding medium
with an amplitude that decays exponentially with distance from the interface. The
penetration depth (at 1/e intensity) of the evanescent field is estimated with respect to
the launch angle using the following expression;56
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(3.2)

where θ is the launch angle, n1 is the refractive index of the waveguide and n2 is the
refractive index of the medium (cladding). For example, if the laser light (λ = 635 nm) is
launched at 760, which is near the critical angle of the waveguide system (n for COC =
1.53, n for PMMA = 1.48), the corresponding penetration depth is ~870 nm, whereas if
the launch angle is increased by 10, the corresponding penetration depth is only 564
nm. Therefore, the appropriate launch angle must be selected in order to obtain the
maximum penetration depth of the evanescent field into the adjacent solution layer to
maximize the amount of sample excited by the evanescent field.
We evaluated the ability of our embedded polymer waveguide for fluorescence
excitation into the adjacent solution by depositing 20 µL of a 1 µM solution of AlexaFluor
647 on the embedded waveguide and placing a thin cover slip on the surface to provide
a uniform thickness of fluid above the waveguide. A 635 nm laser was launched into the
embedded waveguide through the prism and fluorescent signals were collected at
different launch angles using a 2x microscope objective to image the entire length (3
cm) of the waveguide onto a CCD camera (exposure time = 1 s). Figure 3.6a shows a
plot of the fluorescence intensity as a function of launch angle. As can be seen, the
highest fluorescence intensity was obtained at a launch angle of 76o, which is close to
the critical angle of this waveguide. This is expected based on equation 3.2, which
corresponds to the maximum penetration depth of the evanescent field into the
adjoining solution layer.
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To test the ability to generate evanescent excitation with the OFC embedded
waveguide, laser light (635 nm) was coupled into the optical fiber that fed the COC
embedded waveguide. The same Alexafluor 647 solution was sandwiched between the
waveguide and cover slip as described above. Figure 3.6b shows a typical fluorescence
image acquired with the CCD using the OFC waveguide (CCD exposure time = 1
s).These results demonstrate the utility of the OFC waveguide for fluorescence
measurements without beam shaping optics and careful launch angle adjustments,
which are required for prism coupling.
The ability to utilize the waveguide and fluidic architecture after assenbly for
fluorescence measurements in a multi-channel format was also demonstrated by filling
the fluidic channels (see Figure 3.3a) with a 100 nM solution of AlexaFluor 647 and
reading the fluorescence signal from each fluidic channel using the CCD with a 10x
relay objective (NA = 0.5), the results of which are shown in Figure 3.7.
In Figure 3.7a, the fluorescence image from eleven (11) parallel microchannels
(100 µm wide x 30 µm deep with a 100 µm pitch) is shown with a clear demarcation
between the dye-filled channels (fluorescence signal present with a fairly uniform
intensity) and the inter-channel space showing negligible fluorescence signal. To clearly
visualize the waveguide geometry while collecting fluorescence from the fluidic
channels, a low magnification objective (2x, NA = 0.1) was used to acquire a second
image. Figure 3.7b gives the fluorescence image from each fluidic channel with the
region outside the waveguide region showing a dark background. This indicated that
fluorescence excitation was confined to the waveguide area.

110

a

30000

Intensity (CCD cps)

25000

20000

15000

10000

5000

0
76

78

80

82

84

86

88

Launch Angle (Degree)

b

Figure 3.6 (a) Top pane is a typical fluorescence image acquired with CCD when light
was launched into the waveguide with fluorescence solution sandwiched on the surface.
Bottom pane is the plot of fluorescence intensity at different launch angles. (b) Typical
fluorescence image acquired with CCD when laser (light) was coupled into the OFC
waveguide with fluorescence solution sandwiched on the surface with PMMA cover
plate.
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a
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Figure 3.7(a) Fluorescence image acquired from multiple fluidic channels (11 microchannels shown) filled with 100 nM AlexaFluor 647 when light was launched into the
COC core embedded waveguide through the monolithic prism; there was a clear
distinction between channels (with sample) showing fluorescence signal with fairly
uniform intensity ( bottom pane) and inter-channel spacing showing dark background,
image was acquired with a 10x microscope objective (NA = 0.5) (b) Fluorescence image
from the same device acquired with a 2x microscope objective (NA = 0.1) to clearly
reveal the waveguide geometry.
3.4 Conclusion
We have fabricated and evaluated a novel COC core waveguide embedded in
PMMA that was situated orthogonal to multiple fluidic channels along the width of a
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PMMA wafer. This design allowed for fluorescence detection from multiple fluidic
channels using evanescent excitation and a CCD camera for parallel readout. We have
presented and evaluated two methods of launching light into the embedded waveguide;
the use of monolithic prism for effective laser launch into the waveguide and the use of
an optical fiber coupled to the waveguide. The two designs generated an evanescent
field for the wide field excitation of fluorescent dyes traveling above the waveguide in
fluidic channels, which enabled reading fluorescence signal from multiple fluidic
channels in a parallel format. This technology may be particularly attractive for high
throughput or multiplexed sample analyses. In the near future, the waveguide system
will be integrated to a high density fluidic network possessing multiple vias for high
throughput screening of biochemical reactions for drug discovery applications.
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CHAPTER 4
POLYMER-BASED DENSE FLUIDIC NETWORK FOR HIGH THROUGHPUT
SCREENING WITH ULTRASENSITIVE FLUORESCENCE
4.1 Introduction
High Throughput Screening (HTS) is the process of selecting a potential drug
candidate from a pool of diverse chemical elements, and it represents an integral part of
the drug discovery process, which is constantly desiring

improved efficiency by

emerging scientific advances and increasing pressure to reduce drug development
cost.1-5 The number of potential therapeutic targets are rapidly increasing due to a better
understanding of the genetic basis of disease. Also, combinatorial chemical synthesis
has generated large compound libraries for screening against the growing number of
targets. These advancements have placed high demand on drug discovery screening
technologies to provide a suitable platform/system that will enhance throughput in the
screening process. Such screening systems must be able to sustain assay processing
rates of several thousands per run without sacrificing data quality. In addition, screening
platforms must be robust and reliable, cost-effective, simple and user-friendly, and
should be amenable to rapid implementation, standardization and automation to provide
competitive advantages for the operator.6
The primary approach toward providing for this demand and to shorten the time
scale for all aspects of drug discovery has been the adoption of high-density plate
systems characterized by small well volumes capable of screening ~100,000 assays per
day.3,7-9 These systems require sophisticated and highly sensitive detection techniques
to generate high quality assay results due to the small well volume. To provide for this
sensitivity requirement, fluorescence-based detection techniques have become
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increasingly popular in designing miniaturized HTS system due to the inherent
sensitivity advantage of fluorescence measurements.

For example, Modern HTS

technology, such as the Evotec robotic micro-plate systems (EVOscreen Mark-II and
EVOscreen Mark-III)10 employs confocal fluorescence readers to serially address assay
results, and are capable of screening over 100,000 assays/day.10-12 Unfortunately, the
serial strategy associated with the confocal fluorescence scanner places a severe
limitation on the capability of the system to enhance assay throughput. Furthermore, the
implementation of higher density micro-plates with reduced well volumes is faced with a
number of other hurdles. These include, evaporation problems resulting from the high
surface-to-volume ratio (i.e. quick evaporation of dispensed liquid), and the
sophistication required for liquid dispensing. Although, some of these challenges can be
addressed through concerted efforts in engineering of automated micro-plate
workstations for HTS (e.g. the Evotec second generation screening platform,
EVOscreen Mark-III, which utilizes four parallel confocal readers in four detection
channels),10 it comes with enormous price tags, which could be up to several millions of
dollars.
Advances in microfabrication technology has created opportunities for exploring the
potential of microfluidics for HTS.13 These microfabricated devices are capable of
manipulating and processing miniature volumes (10-9 to 10-18 Liter) of fluids in
microchannels with dimensions of a few micrometers, which makes them suitable for
performing continuous flow assays in a miniaturized format. In addition, several
processing units can be configured in a small footprint suitable for optical imaging,
which provides the opportunity for massively parallel experimentation. Furthermore,
microfluidic devices are characterized by their small size and employ hydrodynamic
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pressures or electrokinetic pumping for fluid transportation (fluidflow),14-18 which
facilitates integration to sample detection systems without complex engineering designs.
These unique features of microfluidics

make

them viable platforms for HTS.19,20

Employing microfluidics for HTS technology provides several other advantages,
including, reduction in solvent evaporation problems associated with micro-plates,21 low
consumption of samples and reagents, short time of analysis and the ability to automate
fluid handling.22-25 Another key feature of microfluidics is the ability to integrate several
processing steps into a single system, which simplifies routine operations and also
eliminates sample cross-contamination. For example, it can integrate functions such as
sampling, sample transport, biochemical reactions, analyte separation, product isolation
and detection within a microchannel network.26-28 Consequently, microfluidics provides
the ability for serial sample processing and analysis in a single fluidic element and in
addition, can accomplish massive parallelization brought about by the configuration of
multiple processors in a single device.29
The utility of microfluidics for throughput enhancement in different types of assays
have been demonstrated.30-35 The potential of microfluidics for large-scale biochemical
screening was demonstrated through the use of microfabricated microchannel array
systems with automatic sample loading from microtiter plates, to screen 96 samples in
less than 90 s.36 Other examples of reports that employed microfluidics for high
throughput assays includes on-chip immunoassays for screening fluorescently labeled
antibodies,37 continuous-flow sandwich hybridization assay for pathogen detection,38
integrated microfluidics and bead-based assays for high throughput detection of gene
expression,39 detection of low-affinity transient binding events in biomolecular
interactions,40 parallel screening of in-situ click chemistry,41 kinase assays based on
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separation of reaction products from substrates and cell-based assays.3,42-44 Therefore,
the application of microfluidics in HTS can provide a way to resolve current challenges
in drug screening and significantly increase throughput with minimal operation cost in
drug discovery projects.29
Fabrication of microfluidic devices have been traditionally done in glass and silicon
using technology borrowed from the microelectronics sector.45,46 The attractiveness of
glass as materials for microfluidic fabrication includes their well-defined surface
chemistry, and good electroosmotic properties, which make them compatible with many
biochemical and flow-based assays.

Also, the excellent optical properties of glass

make them suitable for ultra-sensitive fluorescence measurements. However, the
fabrication modalities are time-consuming, challenging and relatively expensive.
Polymers offer important advantages and have attracted much interest in
microfluidic device production due to their simple fabrication characteristics, and in
some cases their favorable optical properties. In addition, they are generally low-cost
materials, which allows for inexpensive mass production of microfluidic devices.47
While microfluidics provide a suitable platform for HTS by generating high number of
sample processing units over a small footprint, a suitable detection system is required
for parallel interrogation of the fluidic processors using wide-field illumination, such that
the resulting fluorescence is imaged onto an array detector possessing the prerequisite
sensitivity for parallel readout. An array detector that can be employed for ultra-sensitive
fluorescence detection is the electron multiplying charge-coupled device (EMCCD) with
frame transfer capabilities to provide for high speed imaging in near video frame rates,
which allows monitoring of biochemical reactions with high efficiency.48-50 Throughput in
this case is directly related to the number of fluidic processors that can be imaged onto
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the detector; therefore, the configuration of the fluidic processors in a high density
format is important to provide increased throughput and to realize the full potential of
microfluidics in HTS.51
In this Chapter, we present a high density fluidic device with a series of individual
sample processors configured in a small footprint suitable for optical imaging. The
device was fabricated using UV-LiGA to first produce the required fluidic structures on a
metal mold (Ni mold master), which was transferred onto a polymer substrate during
replication. The polymer microchip possessed multiple fluidic processors with an
individual input reservoir. An ultrasensitive fluorescence detection system with a large
field-of-view (FoV) was used to transduce fluorescence signals simultaneously from
each fluidic processor onto the active area of an EMCCD. The utility of the multichannel
network for HTS with an optical system for providing the prerequisite sensitivity was
demonstrated by parallel monitoring of fluorescence signal from AlexaFluor 660 labeled
oligonucleotides that were hydrodynamically pumped through individual fluidic channels.
Evaluation of the fluidic system using blank and dye samples indicated the absence of
cross talk between fluidic channels, and thus, indicating the apparent capability for
simultaneous monitoring of multiple biochemical assays as appropriate for HTS.
4.2 Experimental Procedure
4.2.1 Fabrication of the Fluidic Network
The fluidic structures were fabricated using UV-LiGA to produce Ni electroforms
(mold master) according to standard lithography procedures already reported (see also
Chapter 1, Section 1.4.2).52,

53

To achieve a precise depth of 1 μm for the fluidic

channels, SU-8 photoresist was spin coated (3500 rpm; 30 s) on a silicon disc to a
thickness of 1 μm and baked for 1 min at 95oC on a hot plate. A UV mask containing the
121

Figure 4.1 The design of the UV mask containing the fluidic patterns. Three different
patterns were poised on the mask; from top to bottom. 10 μm wide (pitch = 10 μm), 5
μm wide (pitch = 2 μm) and 1 μm wide (pitch = 1 μm) patterns.
fluidic patterns was designed (see Figure 4.1) and used for the UV exposure prior to
development and electroplating steps to make the master mold. The UV mask (see
Figure 4.1) consisted of three different device designs: (1) a 10 μm width (pitch = 10
μm), (2) a 5 μm width ( pitch = 2 μm) and (3) a 1 μm width (pitch = 1 μm) patterns, that
could be used interchangeably to make any of the three different structures (See Qu et
al. for specific details on UV-LiGA procedures52). Hot embossing was used in the
molding step to transfer the fluidic pattern from the mold master onto PMMA substrates
by employing a JenOptik HEX02 high-precision hot embossing system to create high
fidelity in the features over large areas. The fluidic architecture of the high density model
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microchip is shown in Figure 4.2. The device consisted of 25 fluidic processors with
dimensions of 5 μm width, 1 μm depth and a pitch of 2 μm configured in a footprint of
~180 μm in the high density region for optical detection. Figures 4.3a and 4.3b present
SEM images of sections of the molded parts made in PMMA. A PMMA cover plate
(Thickness = 125 μm) was placed on the device to create the fluidic channels and
subsequently fusion bonded to the substrate in a GC oven at 107oC (slightly above the
Tg of PMMA) after being clamped between two glass plates to render uniform pressure
(see Figure 4.3c). Each fluidic processor possessed an individual sample input reservoir
(see Figure 4.3b) for introduction of reactants (enzyme and substrate) and also a
reaction zone equipped with a strip heater for incubation of the enzyme and substrate
and thermal perturbation of the reaction products (see Figure 4.2). The fluidic channels
gradually fan-out (see Figure 4.3 a and c) from the high density region to connect with
the individual sample reservoirs (see Figure 4.3b). The spread of the fluidic channels
provides two advantages: (1) Each fluidic channel serves as an independent sample
processor, which allows for multi-sample interrogation; and (2) generation of adequate
reaction zone (reactors) with sufficient room for incubating enzyme and substrate (see
Figure 4.2) via integration with small heating elements, such as a strip heater to supply
thermal energy to the fluidic processors without negatively impacting the fidelity of the
fluidic channels. The width of the channel is 22 μm at each individual reservoir (see
Figure 4.3b) and tapers to 14 μm at the reaction zone (see Figure 4.3a) and then to 5
μm at the high density (detection) region. All fluidic processors have equal lengths (3
cm) and equal depths (1 μm) from the sample input reservoir to the common reservoir.
This was important to maintain uniform hydrodynamic pressure in all the fluidic
processors. The volume capacity of each individual fluidic processor is ~0.15 nL, which
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Figure 4.2 Schematic of the fluidic network for HTS (1, 2 & 3 are SEMs of a Ni
electroform related to the indicated sections of the device) possessing reactor channels
for incubating the enzyme target with the substrate and potential drug inhibitor. The
dense network of channels for imaging evaluates the efficiency of drug inhibition by
measuring fluorescent signal. The device has a total of 25 fluidic processors configured
in a 180 μm wide footprint.

Figure 4.3 (a) SEM of a section of the molded device in PMMA using hot embossing.
The section shown is where the channels spread out to accommodate individual sample
input reservoirs (b) SEM of one of the channels showing the individual sample input
reservoir. (c) Optical micrograph of a section of the sealed device showing the geometry
of the fluidic network. (d) Optical micrograph of the microchip showing the fluidic
network and the common reservoir.
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provides advantages in terms of reagents economy. All channels possessed a common
output reservoir (see Figure 4.3d) for collection of waste following each assay. A replica
device was also made through the same process but having a width of 10 μm and pitch
of 10 μm (depth = 1 μm).
4.2.2 Optical Set-up and Multichannel Illumination
A wide field-of-view (FoV) fluorescence detection system (details presented in
Chapter 2) was used to monitor fluorescent signals from the fluidic vias using a highly
sensitive EMCCD operated in a frame transfer mode. The optical system was
configured in an epi-illumination format with beam shaping optics and employed a 40x
microscope objective (Numerical Aperture, NA = 0.75) to generate a collimated light
output with a diameter of ~200 μm. At this magnification, the system possessed a FoV
of ~200 μm, which allows interrogation of all 25 fluidic processors simultaneously. The
system is not limited by magnification of the objective and thus accommodates other
microscope objectives with the appropriate NA to expand the FoV. For example a 20x
microscope objective (NA = 0.75) generated a FoV of 400 μm.
4.2.3 Chemicals and Reagents
Tris-Taps-EDTA (TTE) buffer was used for all measurements; 1x TTE

buffer

solution (pH = 8.7) was prepared from a stock solution of the buffer (10x) using
nanopure water obtained from a Barnstead NANOpure System (Model D8991,
Dubuque, IA). AlexaFluor 660 was obtained from Molecular Probes (Eugene, Oregon,
USA) and working solution samples were diluted from a stock solution (80 nM) using 1x
TTE buffer. Buffer solutions were filtered through a 0.2 μm filter prior to sample
preparation.
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4.3 Results and Discussion
4.3.1 Parallel Fluorescence Measurements in the Multichannel Device
Hydrodynamic pumping was used to drive fluid through the device. This was
achieved by connecting a syringe pump to the common reservoir while each fluidic
channel fed with a prepared sample at its appropriate reservoir. The syringe pump was
operated in the refilling mode, which transported the liquid sample from its reservoir
through each fluidic channel at a constant flow rate (linear velocity = 0.03 cm/s). Using
this set-up, a 2.0 nM solution of AlexaFluor 660 was hydrodynamically pumped through
each fluidic channel of the device and a fluorescent signal was acquired simultaneously
from all the fluidic processors. Figure 4.4a is a fluorescence image obtained with the
CCD showing fluorescent signal from all 25 microchannels. With these channel
dimensions (5 μm width, 2 μm pitch), a 20x objective with the same numerical aperture
(NA) as the 40x (NA = 0.75) will generate a FoV of 400 μm, which will allow the
simultaneous fluorescence detection from 50 microchannels. We also investigated
sample throughput with a 10 μm wide channel (pitch = 10 μm) because it was easier to
drive fluid through these larger channels due to lower pressure drop. The fluorophore
was driven through the fluidic channels in the same manner and fluorescent signal
measured. Figure 4.4b shows a fluorescence image from 15 microchannels. This
means that if the 20x objective is used, 30 channels can be imaged using these channel
dimensions.
4.3.2 Investigation of Cross Talk Between Channels
To investigate potential cross talk between the fluidic channels, blank samples (buffer)
and dye samples (AlexaFluor 660) were loaded into the individual sample reservoirs
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and a fluorescence image was acquired. Figure 4.5a shows an image when some
channels were loaded with dye and others loaded with buffer. The channels loaded with
dye gave fluorescent signal while those loaded with the buffer (marked x in Figure 4.5a)
gave no fluorescent signal. Thus, the system could monitor multiple biochemical assays
without cross contamination. This was further explicitly indicated by generating a 3D
image of Figure 4.5a (see Figure 4.5b) to show fluorescent signal profile from channels
loaded with dye samples.

b

a

Figure 4.4 (a) CCD image of fluorescent molecules (AlexaFluor 660) migrating through
the high density chip (channel dimension = 5 μm x 1 μm (pitch = 2 μm). The
fluorescence was collected with a 40x/0.75 objective using a 200 ms CCD exposure
time (25-fluidic channels were imaged (b) CCD image acquired using the same
condition in a wider channel (dimension: 10 μm x 1 μm, pitch = 10 μm); 15 fluidic
channels were imaged.
4.4 Conclusion and Future Work
A novel microfluidic system was fabricated suitable for high throughput screening of
combinatorial libraries for a specific target. The fluidic channels were configured in a
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high density format that could also be optical imaged. We have demonstrated the ability
to carry out simultaneous fluorescence measurements in multiple fluidic channels,
which will allow for multiple assays to be analyzed in a massively parallel fashion. Whilst
a

x x

xx

x xx

x x

x xxxx

b

Figure 4.5 (a) CCD Image acquired when fluidic channels were filled with buffer or dye
(AlexaFluor 660) samples; the locations marked ‘x’ are buffer-filled channels. (b) 3D
image showing the fluorescence intensity profile in channels loaded with AlexaFluor
660; the channels marked x in (a) appeared as a dark background also in (b)
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the present fluidic design yielded a theoretical 50-fold increase in sample throughput
compared to serial strategies for HTS, this throughput can be significantly increased
simply by reducing the channel width. For example, with a channel width of 1 μm (pitch
= 1 μm), 100 fluidic processors can be imaged in an ~200 µm field-of-view. Further
reduction in channel width to 500 nm with a pitch of 500 nm would allow the ability to
image a total of 200 fluidic processors simultaneously using a 40x microscope objective.
The introduction of a 20x microscope objective with high numerical aperture (NA = 0.75)
in this case would generate a throughput of 200-fold for a 1 μm wide channel design
and 400-fold for the 500 nm channel design. The fluidic device will be further evaluated
by screening a small library of compounds against a specific target. For example, L1
endonuclease (L1-EN) is an enzyme responsible for double strand breaks in genomic
DNA and is associated with 45 different diseases, including aging and cancer.54 Also
APE1 is another important target which causes radio- and chemo-resistance in human
tumors.55 A small library of potential therapeutic agents for these important targets will

L1 Endonuclease (Target)
Small Molecule
Inhibitor
F Q

F Q

No
Fluorescence

F – Fluorophore
Q- Quencher

Figure 4.6 A pictorial depiction of a model assay for screening a combinatorial library
for L1-EN and APE1.
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be screened to register drug candidates for clinical trials. The pictorial depiction of a
model screening assay for these targets is shown in Figure 4.6. The small molecule
inhibitor (drug candidate) will be incubated with the enzyme in the presence of an
appropriate substrate containing the action site of the enzyme. The substrate (double
stranded DNA) will be labeled with a fluorophore and a quencher and fluorescence
monitored with proximity considerations to determine the extent of double strand breaks
induced by the enzyme activity. Whilst L1-EN which is a 6-base cutter recognizes
AATTTT motif, APE1 recognizes the apurinic (AP) site in genomic DNA and these sites
will be incorporated in the designed substrate for the screening experiments.
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CHAPTER 5
MICROFLUIDIC DEVICE WITH INTEGRATED CONDUCTIVITY SENSOR FOR
QUANTITATIVE ENUMERATION OF CIRCULATING TUMOR CELLS (CTCS): AN
APPROACH TO CLINICAL EVALUATION OF DRUG EFFICACY
5.1 Introduction
Hematogenous spread of metastatic carcinomas is the reason for most cancerrelated mortalities.1

For Breast cancer, the death rate is estimated to be ~45,000

deaths per year in women.2 Therefore, intensified research effort is required to develop
simple techniques that can monitor the effectiveness of cancer therapies, and at the
same time could support the successful search for suitable therapeutic agents, as well
as promote early diagnosis of the disease to enhance survival rate of cancer patients.
Whilst tumors, such as breast cancer have been traditionally diagnosed using a
combination of radiological, surgical biopsy, as well as pathological assessment of
tissue samples based on morphological and immunohistochemical characteristics,
requiring evaluation of tissue samples under a microscope, the process has proved to
be invasive and time consuming and is also accompanied with high rates of false
positive results, which range from 20 – 50%.3,4 A clear understanding of the stages in
tumor metastases could provide an avenue for developing new tools for early tumor
diagnosis which will allow for appropriate and timely administration of cancer therapies.
Classical views envisioned metastasis as a late process in tumor progression; however,
it has been shown that dissemination of cancer cells to distant organs is an early
process in tumorigenesis, especially in breast cancer.5-7 There are two main routes for
cancer cell dissemination to distant organs; these are the bone marrow (BM) and
peripheral blood of cancer patients. While there is evidence that the BM serves as a
homing reservoir for tumor cells of many types of carcinomas, the peripheral blood
134

serves as a transportation medium through which distant sites are effectively accessed
by tumor cells.8-11 This indicates that the number of tumor cells in peripheral blood and
also in BM can reflect tumor burden at all stages of cancer progression. Therefore, the
detection and characterization of tumor cells in BM and in circulating peripheral blood
has gained significant attention in cancer research.12 Disseminated tumor cells (DTCs)
and circulating tumor cells (CTCs) are two nomenclatures used to describe tumor cells
in bone marrow and peripheral blood, respectively, and both present clinical significance
in cancer management.9
Quantitative assessment of DTCs and CTCs can facilitate early detection of
cancer and its successful treatment, as well as indicating survival probability of cancer
patients.13 In addition, it can be used for real-time monitoring of systemic anticancer
therapies in clinical management of several cancer-related diseases to provide
information such as the success or failure of therapeutic agents.14 Furthermore, it can
serve as an indicator to guide the development and clinical evaluation of new cancer
drugs,12,15,16

for example in the search for suitable therapeutic agents for L1-

Endonuclease and APE1 (see chapter 3).
Although, the detection of DTCs in BM has been hypothesized to be of superior
clinical significance compared to CTCs in blood,17,18

sampling BM for DTCs

enumeration during routine procedures in clinical management of cancer patients is
invasive, time consuming, and uncomfortable for the patients. Moreover, sampling
modality of BM is difficult to perform in certain situations, such as during control visits at
outpatient centers, which can hamper repeated analysis. As a result, efforts have been
concentrated on CTC enumeration in peripheral blood,12,19 which has also assumed a
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leading role in cases such as gastrointerstinal cancer, where dissemination of cancer
cells to BM is rare.20
The major challenge with quantitative enumeration of CTCs is the ability to make
determination of the extremely low abundance of these cells among high numbers of
co-existing cells, such as erythrocytes and leukocytes. For example, 1 mL of whole
blood may harbor < 10 CTCs but have >109 erythrocytes and >106 leukocytes.13
There are two main approaches to CTC detection; these are, immunological
assays (immunocytochemistry) that employ monoclonal antibodies directed against
certain membrane protein targets specifically expressed in cancer cells (e.g.
cytokeratins), and the other being PCR-based molecular assays, such as reverse
transcriptase (RT)-PCR and quantitative PCR (qPCR), which target tissue specific gene
expression,21-23 and utilize detection methods, such as fluorescence in-situ hybridization
(FISH) to identify gene aberrations and measure tumor-associated gene expression.24
Unfortunately, these methods are usually preceded by an enrichment procedure, such
as immunomagnetic bead techniques,25,26 and are associated with poor quantitative
results,27 long preparation times, expensive experimental equipment and lack of
methodological standardization. Thus, developing CTC detection methods that are more
sensitive, and highly reproducible are still required.
Several research findings have shown that cells of different types or in distinct
biological states have different dielectric properties,28-30 and this difference in dielectric
nature has been used to select certain biological cells from mixed populations based on
differential dielectrophoretic (DEP) forces.31-33 Wang et al.34

used this principle in

combination with field-flow-fractionation to separate human breast cancer cells from Tlymphocytes and hematopoietic stem cells. Becker et al.35 also demonstrated that the
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dielectric properties of metastatic human breast cancer cells are significantly different
from those of erythrocytes and T-lymphocytes, and they used a dielectric affinity column
to remove tumor cells from dilute blood. These approaches are based on the fact that
biological cells become electrically polarized when subjected to an alternating electric
field,31 and the degree of polarization of these

cells depends strongly on their

composition, morphology, and phenotype and is also highly dependent on the frequency
of the applied electrical field, thereby enabling the selection of these cells.36 This results
in cells of different types and in different physiological states having distinctly different
dielectric properties. 37
Information secured from electrical impedance spectroscopy (EIS) techniques
opened up another venue for characterizing biological cells based on their electrical
properties.38-40 Han et al.3 employed micro-impedance spectroscopy (µ-EIS) to
discriminate human breast cancer cell lines of different pathological stages from normal
human breast tissue cell lines.
While µ-EIS and DEP have been widely employed for cell characterization, they
are not adept at selecting rare tumor cells from mixed populations due to the low
throughput of these sampling techniques.

Therefore, a more reliable method that

provides high-speed quantitative detection and enumeration of cancer cells is needed.
For example, simple electrical conductivity measurements can be configured in high
flow rate systems to transduce cellular and molecular species traveling through an
electrode pair. This was demonstrated by Galloway et al.41 and McWhorter et al.42 in the
analysis of mono- and poly-anionic molecules and in the detection of polymerase chain
reaction products.
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The fundamental morphology of tumor cells indicates that they possess very low
membrane potential and low impedance, resulting from the migration of the extracellular
sodium ion (Na+) in compensation for the depleted potassium ion concentration (K+) of
the intracellular fluid.43,44 Consequently, these cells are characterized with high
intracellular Na+ concentration.44 This sustained elevation of intracellular sodium acts as
a mitotic trigger causing cells to divide rapidly.45 In the resting phase, normal cells
maintain a high membrane potential at around 60 mV to 100 mV, but when mitosis and
DNA synthesis begin, the membrane potential falls to around 15 mV.46 Thus, an
increased rate of cell division associated with tumor cells constantly keeps them at a
low membrane potential. In addition, tumor cells have different lipid and sterol contents
in their membrane when compared to normal cells.47

This altered membrane

composition disrupts the membrane permeability, which results in the movement of
potassium, magnesium and calcium out of the cell while accumulating sodium and
water in the cell.48 Also, the alteration in the cell membrane content with respect to the
types of glycoproteins and antigens that tumor cells express result in an increase in the
number of negatively charged sialic acid molecules that cap the tips of glycoproteins
and glycolipids that extend outward from the cell membrane.49,50 The inability of tumor
cells to produce cellular energy: adenosine tri-phosphate (ATP) is another factor
responsible for the high rate of transmembrane movement of the mineral contents of the
cell. A steady supply of cellular energy is required to maintain a normal concentration of
intracellular minerals and a healthy membrane potential. These phenomena, which
result in changes in the mineral contents of the cell, increase the intracellular
concentration of positively-charged sodium ions and also generate an increase in
negative charges on the cell coat (glycocalyx),51,52 which are the major factors causing
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cancer cells to have lower membrane potentials compared to healthy cells.53 This
makes tumor cells highly conductive amidst normal erythrocytes and leukocytes, thus
prompting the design of appropriate conductivity systems for their selective
quantification.
Conductivity detection is an electrochemical technique with the ability of
detecting small changes in ionic composition of tiny amount of solution, which could
result from the presence of minute species in a miniaturized system and thus, has found
utility in micro-fluidic applications,41,42,54 in which fluidic channels can be configured to
closely parallel the size of molecular species. The effectiveness of this detection
technique is highly dependent on the electronic design of the conductivity system to
provide optimal sensitivity appropriate for interrogating single cells, such as CTCs.55,56
The conductivity response (G) is defined with the following expression:
G = (λ+ + λ-)C/1000K

(5.1)

where λ+ and λ- (S cm2 equiv-1; S = Siemens) are the limiting ionic conductances of
cations and anions in solution, C is the solution concentration and K is the cell constant
(K = L/A, where L is the distance between the electrode pair and A is the area of the
electrode). Reducing the spacing between the electrodes and/or increasing the area of
the electrodes will increase the magnitude of G (by reducing K) and consequently
improve the detection limit of the conductivity measurement.
In this study, we designed a simple but very sensitive microfluidic-based
conductivity detection system, which was constructed with platinum (Pt) wires that were
integrated into a PMMA-based microfluidic device fabricated by hot-embossing and high
precision micromilling. The fluidic channel and the cell constant (defined by the
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electrode geometry) were carefully scaled to nearly parallel the size of tumor cells. The
detection system demonstrated high efficiency enumeration of tumor cells in seeded
samples that were hydrodynamically transported through the fluidic channels and the
electrode pair. Smaller cells with different electrical properties, such as red blood cells,
were not detected using the present conductivity cell configuration due to low signal-tonoise ratio for this cell type. The ability of the detection system to selectively detect
CTCs in blood samples was demonstrated via its integration with a microfluidic-based,
high throughput micro sampling unit for CTC isolation and subsequent label-free
enumeration without interference from erythrocytes and leucocytes.
5.2 Experimental
5.2.1 Reagents and Materials
Human breast cancer cell line, MCF-7 was used as a model for CTC detection
which was studied along with other co-existing cells in blood: the white blood cells
(WBC) and red blood cells (RBC). The Jurkad E6 cell line was used as a model for
white blood cells in this study.
MCF-7 and WBC were purchased from ATCC cultures, USA. RBC,
tris(hydroxylmethyl)aminomethane (TRIS), glycine, trypsin (proteomic grade) and
Tween-20 detergent were purchased from SIGMA ALDRICH, USA. The measurement
buffer was prepared from TRIS, glycine and Tween-20 detergent using nanopure water
obtained from a Barnstead NANOpure system (Model D8991, Dubuque, IA).
5.2.2 Microscopy
Axiovat 200M (Zeiss) fitted with a CCD video camera (JAI CV 252) was used for
cell visualization and to acquire real time video microscopy information during
conductivity measurement. The video camera was operated at a frame rate of 30 fps.
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5.2.3 Cell Culturing and Sample Preparation
MCF-7 cells were cultured in Dubelco modified Eagle’s medium for 2 days at
37oC, then harvested using 0.25% trypsin and resuspended in the same medium. Prior
to conductivity measurements, a portion of the cell suspension was centrifuged for 2
min at 300 rcf, then washed twice with Tris-glycine buffer (0.18 mM Tris, 47 mM Glycine
and 0.05 % Tween 20) to completely eliminate residual growth medium. The resulting
cells were re-suspended in the same buffer and counted using a hemocytometer to
obtain working samples. WBCs were grown under the same condition as those used for
MCF-7 cells, harvested from the culture plate with slight agitation and re-suspended in
the measurement buffer (Tris-glycine buffer with Tween-20) from which working
samples were obtained as described earlier. A suspension of the RBCs (0.3 mL) was
centrifuged and washed in the buffer (Tris-glycine, Tween-20), then re-suspended in the
same buffer to obtain a stock sample from which dilutions were made and counted
with the hemocytometer to obtain the required cell density.
5.2.4 Design of the Conductivity Detector
The design and electronic layout of the conductivity detector is shown in Figure
5.1. To reduce the effects of parasitic capacitance, Cp, due to wiring and electrode
configuration, a synthetic inductor, L, of 132 mH was designed using a Gyrator circuit.
Gyrators, for a given bandwidth, allow the creation of a high quality factor (Q) of
inductors from resistance and capacitance (RC) components. Q is defined as;
Q = ωL/R

(5.2)

where ω is the angular frequency and R is the series resistance of the inductor, which
represents energy lost by the inductor; Inductors of the size and Q needed would be
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impossible to construct utilizing coils wound on ferrite materials. This inductance was
placed in parallel with the capacitance Cp (produced by the electrical wiring), and the
frequency varied to locate the resonance voltage across L and Cp. Once this resonance
point was found, the voltage across the sample cell would be directly sensitive to
changes in the solution conductivity, Gs. The equation for the impedance of the
equivalent circuit consisting of the sample cell in parallel with the inductor is a thirdorder polynomial that makes the analytical determination of impedance difficult. But for
typical circuit values near resonance, the absolute value of impedance is approximated
with the expression:
/Z/= 1/Gs

(5.3)

where /Z/ is the absolute value of the impedance. The sine wave generator produced a
waveform that could be adjusted from 0 to ±1 V in amplitude and 25–50 kHz in
frequency. A target frequency of 40 kHz was chosen to minimize the impedance due to
the double layer capacitance, Cd, and also hold the inductance to a reasonable value.
This signal was fed to a transconductance amplifier, G1, which converted the sinusoidal
voltage to a current. The gain of G1 was set to 10 µA/V. A current source was needed to
drive the sample cell since a voltage source, with its low output impedance, would
negatively impact the circuit’s Q. For the experiments performed in this study, the
current was set to ±5 µA. The required resonance frequency (f) could be approximated
by the standard parallel resonance equation;

f = 1/2π( LCp)1/2
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(5.4)
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Figure 5.1 Electronic circuit diagram of the detector system. The bipolar waveform
(±0.5V) was supplied by the sine wave oscillator, which was converted to AC current
(±5µA) by the transconductance amplifier. The inductor L (132mH) was configured
parallel to the sample equivalent circuit to cancel out the effect of parasitic capacitance
Cp. The phase adjust was used to compensate for delay signal through the sample cell
while the AD630 delivers phase synchronized signal through the low pass filter (180 Hz)
and offset filter to the amplifier.
The voltage across the sample cell was fed to an analog device (AD630 synchronous
modulator/demodulator, Norwood, MA) that was configured as a phase-sensitive
detector. The AD630’s reference input was driven from the phase-delayed sine wave
oscillator output. This phase adjustment was needed to compensate for phase lags in
the detected sample voltage. This voltage was then fed to a low-pass filter with a cut-off
frequency of 180 Hz. The filter produced an averaged direct current (DC) signal that
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was sent to a differencing amplifier, A1. The difference amplifier serves to null the output
to 0 V, such that any output other than 0 V provided, will be due solely to changes in the
solution capacitance. A high gain amplifier, A2, could amplify small changes in solution
conductivity without saturation of the voltage produced by the buffer itself. A National
Instruments PCI6071E, 12 bit A/D acquisition card was used to convert the analog
signal to 12-bit data.
5.2.5 Fabrication of the Microfluidic Device with Integrated Electrodes for
Conductivity Detection
Figure 5.2A shows the design of the microfluidic device with integrated Pt electrodes.
The device was fabricated by a combination of hot embossing and high precision micromilling as outlined in Figure 5.2B. The Pt wire (76 μm) was perfectly positioned on the
surface of a PMMA wafer and tacked down at both ends with transparent adhesive tape
(see Figure 5.2B). This was followed with embossing of the wire into the PMMA wafer
using hot embossing technology (1200 psi for 4 min at 160oC). Prior to micro-milling, the
PMMA chip with embossed Pt wire was flattened in a GC oven at 107oC for 12 min after
being clamped between a pair of glass plates. A microchannel with dimension of 50 µm
(width) x 80 µm (depth) was then constructed on the PMMA chip by micro-milling across
the Pt wires to generate a pair of electrodes aligned with the wall of the channel. The
distance between the electrodes paralleled the width of the channel (50 µm), thus
generating a cell constant, K = 110 cm-1. The micro-milled channel with the electrode
assembly was sonicated for 2 min in water, dried and cleaned in isopropyl alcohol prior
to being enclosed with a PMMA cover plate (125 µm thick PMMA) by thermal annealing
at 107oC for 22 min to create the fluidic channel and the integrated Pt electrodes. The
detection system possessed a probe volume of 226 pL which was adequate to
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interrogate a single tumor cell traversing the micro electrodes based on size
consideration.
a

b

PMMA

Embossing
PMMA
Milling

Channel

Fluidic
Channel

PMMA

Cover plate

Pt
Electrode

Thermal annealing
PMMA

Channel

Figure 5.2 (a) Optical micrograph of the microfluidic device with integrated Pt
electrodes. (b) Schematic presentation of the fabrication process for generating the
microfluidic device with the integrated Pt electrodes. The Pt wire possessed a diameter
of 76 µm.
5.2.6 Conductivity Measurements
All experiments were carried out using Tris-glycine buffer containing 0.18 mM
Tris, 47 mM glycine and 0.05% vol/vol Tween-20 detergent as earlier mentioned. This
buffer was chosen due to its very low conductivity (~50 µS/cm, pH 7.2) and the fact that
it was able to prevent intercellular adhesion and non-specific adsorption of the cells to
the surfaces of the fluidic chip.

The experimental set-up for the conductivity

measurement is shown in Figure 5.3. The integrated electrode pair (sensor) was
connected to the conductivity detection box that housed the conductivity circuit (see
section 5.2.4) which was used to generate the conductivity signal.

Prior to the

introduction

buffer

of

cell

suspension

into

the
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integrated

device,

the

was

hydrodynamically pumped through the micro-channel using a syringe pump (see set-up
in Figure 5.3), and the signal from the buffer was normalized to 0 (see also section
5.3.1). This was then followed with the cell suspensions (samples) prepared in the same
buffer, which were hydrodynamically pumped through the channel at different flow rates
(0.05 µl/min and 0.02 µl/min) in order to measure conductivity changes as single cells
traversed through the detector. These flow rates were chosen based on the minimum
sampling time (0.1 s) of the data acquisition software and to allow enough detection
time (Td) for a single cell traversing the electrodes. This time was calculated to be 0.3 s
at 0.02 µl/min flow rate and 0.7 s at 0.05 µl/min flow rate. Thus, at higher flow rates, a
cell spending less than 0.1 s in the detection volume (226 pL) will not be detected, and
at lower flow rates, there will be peak broadening due to increased Td and consequently
increasing the length of the experiment. In addition, cell densities were chosen in
agreement with these flow rates so as to keep the probability (Pc) of finding a single cell
in the detection volume low (i.e. Pc < 1).

Figure 5.3 Schematic presentation of the experiment set-up for conductivity detection of
cells and visualization with video microscopy. The fluidic channel was connected to the
syringe pump via a capillary (OD =0.75 µm) and stabilized on a motorized stage of the
video microscope. The video microscope was operated with a 20x microscope objective
to acquire image at a frame rate of 30 fps. The electrode pair was connected to the
detector which supplied the bipolar wave form for interrogating the cells.
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5.3 Results and Discussion
5.3.1 Background Stabilization
The detection system herein reported for single-cell detection was characterized
with a double-layer capacitance Cd and parasitic capacitance Cp (see Figure 5.1) that
could generate high background signals which can mask the small signals generated
from the single cells. To reduce such unwanted interference from the background
signals, the offset filter (see Figure 1) was adjusted to bring the background signal to 0
when only buffer was introduced into the microchannel. The low-pass filter (180Hz) was
used to minimize the random noise resulting from the AC components of the system’s
electronics to further improve the signal-to-noise ratio. Figure 5.4 shows a background
adjusted conductivity plot of Tris-glycine buffer pumped through the microchannel. The
absence of signal perturbations clearly indicates the stability of the generated signal and
the conductivity electronics. In addition, no evidence of Faradaic reactions can be seen
from this plot, which would generate “spikes” in the trace due to gas evolution. The
absence of Faradaic reactions results from the bipolar pulse voltage waveform used at
a frequency of 40KHz, which prevents double layer formation within the cell.41
5.3.2 Conductivity Measurement of Cell Suspensions
Conductivity measurements were performed using different cell densities and
various flow rates (0.02 µL/min and 0.05 µL/min). Figure 5.5 shows the results obtained
when MCF-7 cells at a concentration of 150 cells/µL (cell suspension prepared in buffer
and counted with hemocytometer) was hydrodynamically transported through the device
at a flow rate of 0.02 µL/min. Fifty-eight signals were registered (counted) from the
volume (0.33 µL) processed, which indicated the presence of 58 cells with each signal
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Figure 5.4 Background-adjusted conductivity plot with only the measurement buffer
(Tris-glycine buffer) contained in microchannel. Experiment conditions used were; 40
KHz frequency, ±0.5V bipolar voltage, ±5µA alternating current (AC current), and a flow
rate of 0.02µl/min
representing a single tumor cell as confirmed by video microscopy. With these values,
the concentration measured was calculated to be 175 cells/µL, which agrees favorably
to the input concentration. Figure 5.6 is the result obtained from MCF-7 cells using a
concentration of 146 cells/µl and a flow rate of 0.05 µL/min. At these conditions, the
number of cells registered was 122 cells and the total volume processed was 0.83 µL,
providing a measured cell concentration of 147 cells/µL, again agreeing favorably to
input concentration. Based on these observations, the detection and sampling efficiency
of the detection system was estimated as ~100%.
Conductivity signals were verified with video microscopy (see Figure 5.3)
acquired in real time with the conductivity measurement to confirm that each signal
resulted from a single tumor cell traversing the electrodes. A video frame image of such
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real time video acquisition is shown in Figure 5.7. The peak width obtained using 0.05
µl/min flow rate (see Figure 5.6) appeared smaller than those obtained using 0.02
µl/min flow rate (see Figure 5.5), which agrees with our expectations due to differences
in transit time (i.e Td) of the cells in the detection volume at the different flow rates. The
cell densities (or cell concentration) of 146 cells/µL and 150 cells/µL were used with
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Figure 5.5 Conductivity response from MCF-7 cells ([cell] = 150 cells/µL) using trisglycine buffer as the suspension medium and at a flow rate of 0.02 µl/min. Upper panel
shows signal obtained over 1000s with a total of 58-cells registered from the volume
processed (0.33 μL), the lower panel shows the signal over the first 300s. Experiments
were run at a sampling time of 0.1s using ±5µA AC current, ±0.5 bipolar voltage, and
40KHz frequency.
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these flow rates to keep the probability of finding a single cell in the detection volume
per second at ~0.12 and ~0.05 respectively. This is important to avoid double
occupancy during signal acquisition.
Because the goal of this project was to transduce and enumerate the presence of
CTCs selected from whole blood, we anticipated that trace levels of white blood cells or
red blood cells may be present in the sample to be interrogated using conductivity
detection due to the high abundance of these cell types compared to the CTCs. For
example, in 1 mL of whole blood, the number of white blood cells (WBCs) can be on the
order of >106, and the red blood cell (RBCs) population could be >109.13 In this same 1
mL of whole blood, the CTC abundance can be as low as <10 cells. Even if molecular
recognition of particular integral membrane proteins specific for the CTCs were used to
capture these cell types, residual WBCs or RBCs may be present due to non-specific
types of interactions. The presence of these cells could give rise to false positives.
Therefore, we investigated the ability of our conductivity detector to transduce WBCs
and RBCs.
Measurement of WBC cell suspensions containing 150 cells/µL was carried out
with the conductivity detector using a flow rate of 0.05 µL/min. Figure 5.8

shows the

resulting conductivity response, clearly indicating that no signal were observed as these
cells traversed through the electrode pair. Video microscopy revealed that the cells
were traveling through the micro-electrodes, but during their observed travel, no
conductivity signal from these cells was observed.
We next evaluated the ability of the conductivity detector to transduce RBCs.
Conductivity measurement of RBC sample concentration of 150 cells/µL was generated;
the resulting response is shown in Figure 5.8. As can be seen, no visible conductivity
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Figure 5.6 Conductivity response from MCF-7 cells ([cell] = 146 cells/ µL using trisglycine buffer as the suspension medium and at a flow rate of 0.05 µL/min. Upper panel
shows signal obtained over 1000s with a total of 122-cells registered from the volume
processed (0.83 μL), the lower panel shows the signal over the first 200s. Experiments
were run at a sampling time 0.1s using ±5µA AC current, ±0.5 bipolar voltage, and
40KHz frequency.
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changes were observed as the RBCs traversed the electrode pair. The travel of single
RBCs through the electrode pair was again verified using video microscopy.
The absence of signals produced for the RBCs and WBCs in the present case is
due to both the electrical properties of these cells and their morphology (i.e., cell size).
In the present case, the conductivity response that is elicited is due to changes in the
bulk solution conductance of the volume present between the electrode pair when
single cells are resident within this volume. In the case of the tumor cells, their larger
sizes compared to the WBCs and RBCs induces a larger perturbation on the measured
conductance when they are resident in this interstitial space. For example, the average
volume size of a CTC is 14 pL (d = 30 µm), for a RBC it is 0.06 pL (d = 5 µm) and finally
the WBC volume is 1.7 pL (d = 15 µm). In our case, the interstitial volume between the
electrodes is 226 pL and therefore, a CTC occupies 7% of this interstitial volume, while
for RBCs it is only 0.03% and 0.7% for the WBC. Therefore, more buffer and its ionic
components are displaced when a CTC is resident between the electrodes as
compared to a RBC or WBC. In addition, the high ionic content of tumor cells and their
low membrane potentials provides a much higher conductivity compared to RBCs and
WBCs. These factors indicate that a much larger perturbation on the bulk solution
conductance is affected when a tumor cell is present in the probing volume. While the
RBCs and WBCs do produce a difference in the bulk solution conductance when they
are resident in the probing volume, the perturbations is below the SNR of the
measurement and as such, are not seen. Scaling down the size of the probing volume
by reducing the electrode size and spacing would provide better opportunities for
transducing these cells (i.e. in cases

where their signals is vital, for example in

apoptosis study) using conductivity detection.
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5.3.3 Calibration Plot
To establish the counting efficiency of our detector with regards to CTCs,
different cell densities (10 -250 cells/µL, in tris-glycine buffer) were measured using the
same experiment conditions (±0.5 V bipolar voltage, ±5 µA AC current, 40 KHz
frequency and 0.05 µL/min flow rate). Five replicate measurements were averaged and
a calibration plot was constructed (see Figure 5.9). The obtained slope (0.998) and
correlation coefficient (r = 0.9998) clearly indicates the high accuracy and precision of
the detector in enumerating CTCs.

Figure 5.7 Video frame image acquired with video microscope showing a tumor cell as
it traversed the electrode pair. This image was acquired in real time with conductivity
measurement.
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Figure 5.9 Calibration plot of different cell (MCF-7) densities (10 - 250 cells/µL in Tris
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processed at 0.05 µL/min flow rate using ±0.5V bipolar voltage, ±5µA AC current, and
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5.4 Integration of the Conductivity Detection System with a High Throughput
Microsampling Unit (HTMSU) for CTCs Detection in Clinical Samples
The detection system herein reported was recently integrated with a high
throughput microsampling unit (HTMSU) for label-free enumeration of isolated CTCs
from whole blood.57 The HTMSU contains 51 microsampling units (MSU), which were
fabricated in PMMA and decorated with monoclonal antibody to specifically isolate
CTCs from whole blood (see Figure 5.10). As a model clinical sample, citrated blood (1
mL) was seeded with 10 CTCs (MCF-7 breast cancer cell line) and processed with the
HTMSU. Subsequently, a proteolytic CTC releasing buffer (Trypsin-tris-Glysine Buffer)
was used to detach the captured CTCs from the HTMSU for label-free enumeration with
the integrated conductivity sensor. In this study, 8 CTCs were successfully counted (see
Figure 5.10E), which demonstrated high efficiency detection. In a similar assay, the
system has been employed in enumerating prostate cancer cells (LNCaP) from blood
samples.
5.5 Conclusion and Future Work
A highly sensitive integrated conductivity detector system consisting of a pair of
Pt electrodes was developed for a PMMA-based microfluidic device to identify and
enumerate CTCs isolated from clinical samples. The detector was able to detect CTCs,
but due to scaling issues and their electrical properties, RBCs and WBCs could not be
transduced. This is particularly attractive in this application, since the device is targeted
for transducing CTCs and thus, will eliminate false positive signals generated from
these interfering species. In addition, the conductivity transduction modality adopted
herein will generate precise and accurate quantitative measurements of tumor cells
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without the need for cell staining. This has already been demonstrated with high
efficiency via integration with microsystems for label-free enumeration of isolated CTCs
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Figure 5.10 Top (labeled a) is the schematics of the HTMSU showing the integrated
conductivity sensor (labeled b), a single port exit for detached cells (labeled c) and the
sinusoidal cell capture channels (labeled d). Bottom (labeled e) is the conductivity
response from a 1.0 mL of whole blood spiked with 10 CTCs and processed in the
HTMSU followed by detachment (using a releasing buffer that was hydrodynamically
pumped through the device at a flow rate of 0.05 μL/min) and enumeration of the CTCs.
8 CTCs were scored as indicated by the arrow. Adapted with permission.57
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from whole blood associated with breast cancer,57 and Prostate cancer (see section
5.4). In the experiment reported herein, tumor cells, RBCs and WBC were only used as
examples; the detector can be configured to other application areas as well, such as
selecting biopathogens from environmental or clinical samples. Furthermore, the
detection system can serve as a tool for investigating the efficacy of therapeutic agents
by monitoring CTCs from blood samples of patients under clinical management. This
could expand its utility to clinical evaluation of drug candidates in the drug discovery
process (e.g. clinical trial).
We are currently working on the detection and quantification of pathogens and
bacteria in environmental samples as well as biological samples with a careful
manipulation of their electrical properties. Tumor cells of epithelia origin including those
of liver, colon, duodenum, bladder, Lung and stomach are currently being cultured for
further application of this method. The detection and quantification of these mixed cells
will be followed with molecular profiling using a highly sensitive fluorescence detection
method for diagnostic information (see Chapter 2).
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CHAPTER 6
SUMMARY AND FUTURE WORK
6.1 Summary
Microfluidics and single molecule detection (SMD) technologies were integrated with
wide-field fluorescence technology to provide the ability to monitor biochemical
reactions in a high throughput format with single molecule sensitivity. This integration of
unique technologies presents an approach to revolutionize the drug discovery process
through massive parallelization of processing units to increase data production rates
while at the same time generating assay results with high statistical accuracy. The
economic advantage of this integrated technology brought about by the exquisite
capability for sample miniaturization to conserve precious biological reagents will
undoubtedly minimize the cost of registering a validated drug for therapeutic
administration. In addition, the system eliminates several bottlenecks associated with
current technology for high throughput screening (HTS), which will greatly reduce
automation complexities in drug discovery.
Background information related to SMD with emphasis on single molecule
fluorescence was outlined in chapter 1. A thorough explanation of the basic principle of
SMD together with the photophysical phenomena that impact fluorescent signal from
single molecules was presented. In addition, Advances in single molecule fluorescence
technology and its biochemical applications as well as the merger of microfluidics to
SMD were discussed and reviewed.
In chapter 2, the design, performance and application of a novel wide-field optical
system for high throughput SMD configured in a continuous flow format using
microfluidics was presented. The system consisted of a microfabricated polymer-based
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multi-channel fluidic network situated within the field-of-view (FoV) of the optical system
for parallel sample processing. Photo transduction of molecular fluorescent signal was
accomplished using an electron-multiplying CCD (EMCCD) operated in a frame transfer
mode that allowed tracking single molecules as they passed through the illumination
zone, as well as allowing for high speed data acquisition with 100 % duty cycle. The
system was used to monitor biochemical reactions with single molecule sensitivity in a
high throughput format.
In chapter 3, a novel cyclic olefin copolymer (COC) core waveguide embedded in
PMMA and situated orthogonal to multiple fluidic channels along the width of a PMMA
wafer was constructed and described. The waveguide system allowed for fluorescence
detection from multiple fluidic channels using evanescent excitation and a CCD camera
for parallel readout. Two methods of launching light into the embedded waveguide were
evaluated; the use of a monolithic prism for effective laser launch into the waveguide
and the use of an optical fiber coupled to the waveguide. The two designs generated a
sufficient evanescent field for the wide field excitation of fluorescent dyes traveling
above the waveguide in fluidic channels, which enabled reading fluorescent signal from
multiple fluidic channels in a parallel format.
In chapter 4, a high density fluidic device with series of individual sample
processors (fluidic network), configured in a small footprint suitable for optical imaging,
was presented. The polymer microchip possessed multiple fluidic processors with an
individual input reservoir for multi-sample analysis. An ultrasensitive fluorescence
detection system with a large field-of-view (FoV) was used to transduce fluorescence
signal simultaneously from each fluidic processor onto the active area of an electron
multiplying charge coupled device (EMCCD). The utility of the multichannel network for
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HTS with an optical system for producing the prerequisite sensitivity was demonstrated
by parallel detection of fluorescent and non-fluorescent samples in the individual fluidic
processors. In the present configuration, the fluidic system was characterized with 50fold increase in sample throughput and a projected 400-fold increase with slight
modification in channel dimensions.
In chapter 5, the construction of a novel microfluidic device with integrated
conductivity sensor for quantitative enumeration of circulating tumor cells (CTCs) was
described in detail. The system was designed to transduce conductivity signal from the
few copies of CTCs present in blood without interference from the vast amount of coexisting erythrocytes and leukocytes. The conductivity transduction modalities
generated precise and accurate quantitative measurements of tumor cells without the
need for cell staining. The system presents an approach to the design of a viable tool
for investigating the efficacy of therapeutic agents by monitoring CTCs in blood samples
of patients under clinical management.
6.2 Future Work
6.2.1 HTS with APE1 as Therapeutic Target
As alluded previously in chapter 4 (section 4.4), a combinatorial library of
potential drug candidates will be screened against APE1, a target that has been linked
to radio- and chemo-resistance in human tumors. An oligonucleotide duplex will be
designed to possess the apurinic (AP) site recognized by APE1. The substrate will be
labeled with a fluorophore at the 5’-end of the sense strand and a quencher at the 3’end of the antisense strand (see Figure 3.5). The high density fluidic device presented
in chapter 4 and the optical system presented in chapter 2 will be employed in the
screening experiments to monitor fluorescence signal from individual reactor channel
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resulting from molecular perturbation in the substrate due to the activity of the enzyme
in the presence of a small molecule inhibitor.
6.2.2 HTS with L1-Endonuclease (L1-EN) as Therapeutic Target
Similar to the assay described above, a library of small molecule inhibitors will be
screened against L1-EN. In this case, the substrate will be designed to possess the
consensus site (AATTTT motif) recognized by this enzyme (L1-EN).
6.2.3 Throughput Enhancement via Increased Fluidic Channel Density
A slight modification in the dimensions of the fluidic device presented in chapter 4
will be adopted to increase the number of individual reactor channels (increase the
packing density of the channels) that can be probed in parallel using our optical system
to further increase throughput in our HTS campaign. The production of a 1 μm wide
channel (pitch = 1 μm) has commenced, which will allow interrogation of 100 vias when
the system is operated with FoV of 200 μm, and 200 vias when the system is operated
with FoV of 400 μm. The channel dimensions will be driven further to 500 nm (pitch =
500 nm), which will double the throughput by allowing interrogation of 200 vias and 400
vias using FoV of 200 μm and 400 μm respectively. These throughputs are higher than
anticipated from our proposed microfluidic system for HTS (see Introduction: section
1.5, Figure 1.3).
6.2.4 Integration of the High Density Fluidic Network with Embedded Orthogonal
Waveguide
The high density fluidic network described in chapter 4 will be integrated with the
embedded orthogonal planar waveguide described in chapter 3. This integration will
provide a system that will enhance fluorescence sensitivity in our HTS experiments.
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6.2.5 Fluorescence Multiplexing Using Two-color Detection
The next goal of this project will be to modify the optical detection system
presented in chapter 2 for two color detection. To achieve this color multiplexing
capability, a spectrograph will be incorporated into the optical system for spectral sorting
of fluorescence from different molecular species using two excitation sources. The two
color excitation sources have already been constructed and shall be built upon to
realize this goal.
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